<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Video games for people with schizophrenia - Roberts, MT - 2021 | Cochrane Library</title> <meta content="Video games for people with schizophrenia - Roberts, MT - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012844.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Video games for people with schizophrenia - Roberts, MT - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012844.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012844.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Video games for people with schizophrenia" name="citation_title"/> <meta content="Matthew T Roberts" name="citation_author"/> <meta content="Cochrane Collaboration" name="citation_author_institution"/> <meta content="Matthew_T_Roberts@outlook.com" name="citation_author_email"/> <meta content="Jack Lloyd" name="citation_author"/> <meta content="London Ambulance Service NHS Trust" name="citation_author_institution"/> <meta content="Maritta Välimäki" name="citation_author"/> <meta content="Grace WK Ho" name="citation_author"/> <meta content="The Hong Kong Polytechnic University" name="citation_author_institution"/> <meta content="Megan Freemantle" name="citation_author"/> <meta content="Hull York Medical School, University of Hull" name="citation_author_institution"/> <meta content="Anna Zsófia Békefi" name="citation_author"/> <meta content="Eötvös Loránd University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD012844.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/02/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012844.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012844.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012844.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Activities of Daily Living; Bias; Cognitive Remediation [*methods]; Confidence Intervals; Patient Dropouts [statistics &amp; numerical data]; Physical Fitness; Quality of Life; Randomized Controlled Trials as Topic; Schizophrenia [*therapy]; Schizophrenic Psychology; Social Interaction; Standard of Care; *Video Games" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012844.pub2&amp;doi=10.1002/14651858.CD012844.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ytRBD0EW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012844\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012844\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","ms","ja","hr","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012844.pub2",title:"Video games for people with schizophrenia",firstPublishedDate:"Feb 4, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012844.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012844.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012844.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012844.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012844.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012844.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012844.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012844.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012844.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012844.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7764 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012844.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0205"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0090"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-sec-0177"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/supinfo/CD012844StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/supinfo/CD012844StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Video games for people with schizophrenia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Matthew T Roberts</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0005">Jack Lloyd</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0006">Maritta Välimäki</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0007">Grace WK Ho</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0008">Megan Freemantle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information#CD012844-cr-0009">Anna Zsófia Békefi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information/en#CD012844-sec-0220">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 February 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012844.pub2">https://doi.org/10.1002/14651858.CD012844.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012844-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012844-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012844-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012844-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012844-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012844-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012844-abs-0001" lang="en"> <section id="CD012844-sec-0001"> <h3 class="title" id="CD012844-sec-0001">Background</h3> <p>Commercial video games are a vastly popular form of recreational activity. Whilst concerns persist regarding possible negative effects of video games, they have been suggested to provide cognitive benefits to users. They are also frequently employed as control interventions in comparisons of more complex cognitive or psychological interventions. If independently effective, video games ‐ being both engaging and relatively inexpensive ‐ could provide a much more cost‐effective add‐on intervention to standard treatment when compared to costly, cognitive interventions. </p> </section> <section id="CD012844-sec-0002"> <h3 class="title" id="CD012844-sec-0002">Objectives</h3> <p>To review the effects of video games (alone or as an additional intervention) compared to standard care alone or other interventions including, but not limited to, cognitive remediation or cognitive behavioural therapy for people with schizophrenia or schizophrenia‐like illnesses. </p> </section> <section id="CD012844-sec-0003"> <h3 class="title" id="CD012844-sec-0003">Search methods</h3> <p>We searched the Cochrane Schizophrenia Group's Study‐Based Register of Trials (March 2017, August 2018, August 2019). </p> </section> <section id="CD012844-sec-0004"> <h3 class="title" id="CD012844-sec-0004">Selection criteria</h3> <p>Randomised controlled trials focusing on video games for people with schizophrenia or schizophrenia‐like illnesses. </p> </section> <section id="CD012844-sec-0005"> <h3 class="title" id="CD012844-sec-0005">Data collection and analysis</h3> <p>Review authors extracted data independently. For binary outcomes we calculated risk ratio (RR) with its 95% confidence interval (CI) on an intention‐to‐treat basis. For continuous data we calculated the mean difference (MD) between groups and its CI. We employed a fixed‐effect model for analyses. We assessed risk of bias for the included studies and created a 'Summary of findings' table using GRADE. </p> </section> <section id="CD012844-sec-0006"> <h3 class="title" id="CD012844-sec-0006">Main results</h3> <p>This review includes seven trials conducted between 2009 and 2018 (total = 468 participants, range 32 to 121). Study duration varied from six weeks to twelve weeks. All interventions in the included trials were given in addition to standard care, including prescribed medication. In trials video games tend to be the control for testing efficacy of complex, cognitive therapies; only two small trials evaluated commercial video games as the intervention. We categorised video game interventions into 'non‐exergame' (played statically) and 'exergame' (the players use bodily movements to control the game). Our main outcomes of interest were clinically important changes in: general functioning, cognitive functioning, social functioning, mental state, quality of life, and physical fitness as well as clinically important adverse effects.<br/><br/>We found no clear difference between non‐exergames and cognitive remediation in general functioning scores (Strauss Carpenter Outcome Scale) (MD 0.42, 95% CI −0.62 to 1.46; participants = 86; studies = 1, <i>very low‐</i> quality <i>evidence</i> ) or social functioning scores (Specific Levels of Functioning Scale) (MD −3.13, 95% CI ‐40.17 to 33.91; participants = 53; studies = 1, <i>very low‐</i> quality <i>evidence</i> ). There was a clear difference favouring cognitive remediation for cognitive functioning (improved on at least one domain of MATRICS Consensus Cognitive Battery Test) (RR 0.58, 95% CI 0.34 to 0.99; participants = 42; studies = 1, <i>low‐</i> quality <i>evidence</i> ). For mental state, Positive and Negative Syndrome Scale (PANSS) overall scores showed no clear difference between treatment groups (MD 0.20, 95% CI −3.89 to 4.28; participants = 269; studies = 4, <i>low‐</i> quality <i>evidence</i> ). Quality of life ratings (Quality of Life Scale) similarly showed no clear intergroup difference (MD 0.01, 95% CI −0.40 to 0.42; participants = 87; studies = 1, <i>very low‐</i> quality <i>evidence)</i> . Adverse effects were not reported; we chose leaving the study early as a proxy measure. The attrition rate by end of treatment was similar between treatment groups (RR 0.96, 95% CI 0.87 to 1.06; participants = 395; studies = 5, <i>low‐</i> quality <i>evidence</i> ).<br/><br/>One small trial compared exergames with standard care, but few outcomes were reported<i>.</i> No clear difference between interventions was seen for cognitive functioning (measured by MATRICS Consensus Cognitive Battery Test) (MD 2.90, 95% CI ‐1.27 to 7.07; participants = 33; studies = 1, <i>low‐</i> quality <i>evidence)</i> , however a benefit in favour of exergames was found for average change in physical fitness (aerobic fitness) (MD 3.82, 95% CI 1.75 to 5.89; participants = 33; studies = 1, <i>low‐</i> quality <i>evidence)</i>. Adverse effects were not reported; we chose leaving the study early as a proxy measure. The attrition rate by end of treatment was similar between treatment groups (RR 1.06, 95% CI 0.75 to 1.51; participants = 33; studies = 1). </p> <p>Another small trial compared exergames with non‐exergames. Only one of our main outcomes was reported ‐ physical fitness, which was measured by average time taken to walk 3 metres. No clear intergroup difference was identified at six‐week follow‐up (MD −0.50, 95% CI −1.17 to 0.17; participants = 28; studies = 1, <i>very low‐</i> quality <i>evidence)</i>. </p> <p>No trials reported adverse effects. We chose leaving the study early as a proxy outcome.</p> </section> <section id="CD012844-sec-0007"> <h3 class="title" id="CD012844-sec-0007">Authors' conclusions</h3> <p>Our results suggest that non‐exergames may have a less beneficial effect on cognitive functioning than cognitive remediation, but have comparable effects for all other outcomes. These data are from a small number of trials, and the evidence is graded as of low or very low quality and is very likely to change with more data. It is difficult to currently establish if the more sophisticated cognitive approaches do any more good ‐ or harm ‐ than 'static' video games for people with schizophrenia. </p> <p>Where players use bodily movements to control the game (exergames), there is very limited evidence suggesting a possible benefit of exergames compared to standard care in terms of cognitive functioning and aerobic fitness. However, this finding must be replicated in trials with a larger sample size and that are conducted over a longer time frame. </p> <p>We cannot draw any firm conclusions regarding the effects of video games until more high‐quality evidence is available. There are ongoing studies that may provide helpful data in the near future. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012844-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012844-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012844-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012844-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012844-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012844-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012844-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012844-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012844-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012844-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012844-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012844-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012844-abs-0002" lang="en"> <h3>Video games for schizophrenia</h3> <p><b>Review question</b> </p> <p>Are video games an effective treatment (on their own or as an add‐on) for improving the well‐being and functioning of people with schizophrenia or schizoaffective disorder? </p> <p><b>Background</b> </p> <p>Schizophrenia is a severe mental illness that affects people worldwide. People with schizophrenia often have a distorted view of reality ‐ perceiving things that are not present (hallucinations) and believing things that are not true (delusions). People with schizophrenia may struggle to motivate themselves, experience anxiety and depression, and encounter cognitive symptoms, often struggling to stay focused on day‐to‐day activities and becoming disorientated. Hallucinations and delusions are usually treated with antipsychotic medications, whereas other symptoms can be difficult to manage with medication alone. </p> <p>Psychological therapies are sometimes used alongside medication to help with some symptoms of schizophrenia, however these therapies can be complex and expensive. Video games are a relatively inexpensive, and, for many, engaging treatment. They have been suggested to help improve the cognitive impairments such as lack of focus or poor memory that people with schizophrenia often experience. If effective, video games could provide a simple and relatively low‐cost additional treatment for people with schizophrenia. </p> <p><b>Searching</b> </p> <p>We searched for randomised controlled trials (a type of study in which participants are assigned to one of two or more treatment groups using a random method) involving people with schizophrenia receiving either a video game intervention or other type of treatment such as talking (cognitive) therapy or placebo (dummy treatment). We performed the searches in March 2017, August 2018, and August 2019. </p> <p><b>Results</b> </p> <p>Seven trials met our inclusion criteria and provided useable data. Video game interventions were categorised into those that involved movements of the body ('exergames') and those that did not ('non‐exergames'). Non‐exergame trials compared the video game intervention to a form of "brain‐training" therapy known as cognitive remediation. One trial compared exergames to standard care, and another compared non‐exergames with exergames. All interventions in the included trials were given in addition to standard care. </p> <p>The currently available evidence suggests that non‐exergames may not be as beneficial for cognitive functioning as cognitive remediation, but there were no other clear differences between non‐exergames and cognitive remediation for improving functioning in people with schizophrenia. The more exercise‐orientated video games may have some benefit compared to standard care for improving physical fitness. We cannot draw any firm conclusions regarding the effects of video games until higher‐quality evidence is available. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012844-sec-0205" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012844-sec-0205"></div> <h3 class="title" id="CD012844-sec-0206">Implications for practice</h3> <section id="CD012844-sec-0206"> <p>Given the low‐ and very low‐quality evidence from studies at high risk of bias for several ‘Risk of bias’ domains, it is difficult to draw any solid conclusions from the data. </p> <section id="CD012844-sec-0207"> <h5 class="title">1. For people with schizophrenia</h5> <p>For non‐exergames, we found no high‐quality evidence that the complex cognitive interventions examined in this review have any meaningful advantage over video games. A person with schizophrenia may prefer the thought of playing video games rather than receiving a cognitive intervention of equal benefit, although caution should be taken to moderate the quantity of time spent using such games. </p> <p>If a person with schizophrenia wants to help control their weight or fitness, and likes video games, an exergame may be indicated given the ‐ admittedly weak ‐ data supporting aerobic fitness found in this review. Due to limitations with other forms of bodily movements, such as cost, time constraints, and disinterest, exergames games may provide an efficient alternative (<a href="./references#CD012844-bbs2-0101" title="LeutwylerH , HubbardEM , VinogradovS , DowlingGA . Videogames to promote physical activity in older adults with schizophrenia. Games for Health Journal2012;1(5):381-3.">Leutwyler 2012</a>). However, more data are needed to be certain about this effect. Because more studies are needed, people with schizophrenia could help by volunteering to be part of an evaluative study in this area; we suggest that any such participation be done on the condition that all resulting data are made publicly available. </p> </section> <section id="CD012844-sec-0208"> <h5 class="title">2. For clinicians</h5> <p>The data examined in this review do not establish that video games can provide substantial benefit for people with schizophrenia. There is low‐quality evidence suggesting that cognitive remediation may have an effect on cognitive functioning; however, there is insufficient high‐quality evidence to suggest that the cognitive remediation therapies examined in this review are any better than video games. </p> <p>There is the suggestion of some improvement in physical fitness from exergames. This is important, as there are many therapeutic approaches for people with schizophrenia have shown no impact on this population. Exergames are experimental ‐ and more data are needed ‐ but limited evidence indicates that they may benefit the aerobic fitness level of people with schizophrenia. </p> </section> <section id="CD012844-sec-0209"> <h5 class="title">3. For policymakers</h5> <p>This review suggests that non‐exergames are no more or less effective than cognitive remediation. One course of cognitive remediation (40 sessions) has been (conservatively) calculated to cost around GBP 632 (<a href="./references#CD012844-bbs2-0117" title="PatelA , KnappM , RomeoR , ReederC , MatthiassonP , EverittB , et al. Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis. Schizophrenia Research2010;120(1-3):217-24. [PMID: 20056391]">Patel 2010</a>). This is considerably more expensive than the newest video games, plus their consoles. One role of a policymaker is to try to balance how much an intervention costs with the potential benefit of the intervention in people living with schizophrenia, thus such cost differentials must be taken into account. </p> <p>All data in this review are limited, and we consider that no intervention examined herein is supported by data to encourage general implementation. However, should those funding research be considering evaluating the effects of video games, we would suggest supporting exergame research over standard video non‐exergames (see <a href="#CD012844-sec-0210">Implications for research</a>). </p> </section> </section> <h3 class="title" id="CD012844-sec-0210">Implications for research</h3> <section id="CD012844-sec-0210"> <section id="CD012844-sec-0211"> <h5 class="title">1. General</h5> <p>We excluded 41 trials that were fit for inclusion but fell short due to poor reporting (see <a href="./references#CD012844-sec-0227" title="">Characteristics of excluded studies</a>). With the exception of three trials, all included, excluded, and ongoing studies described in this review were published post‐1996, and therefore should all have adhered to the CONSORT Statement (<a href="http://www.consort-statement.org" target="_blank">CONSORT</a>). Conforming to CONSORT would have improved reporting of clinical trials, increasing availability of data and easing interpretation for reviewers and consequently readers. </p> </section> <section id="CD012844-sec-0212"> <h5 class="title">2. Specific</h5> <section id="CD012844-sec-0213"> <h6 class="title">2.1 Reviews</h6> <p>In our protocol we specified that we would not include studies that involved participants at 'high risk of psychosis'. We excluded four different studies due to them being 'high risk' studies. We feel that 'high risk' should be its own, unique population and could be reviewed as a separate entity. This and other reviews suggested by the excluded studies are tabulated in <a href="#CD012844-tbl-0005">Table 2</a>. Furthermore, this review generated three different comparisons. The comparison with the most data is 'video games versus cognitive remediation', which again we feel could be reviewed separately given a more specific search is carried out. A separate review of cognitive remediation as a whole will be beneficial. This would also allow some conclusions to be drawn regarding whether the similar effect of video games to cognitive remediation, as seen in this review, stands to the credit of video games, or the detriment of cognitive remediation. </p> </section> <section id="CD012844-sec-0214"> <h6 class="title">2.2 Further studies</h6> <p>Trials investigating the effects of video gaming that have been designed well and conducted and reported to a high quality are needed. Considering that there was no difference between video gaming and the complex cognitive interventions, we suggest that a trial where video gaming is the experimental group is warranted. Data were severely lacking in this area. </p> <p>This review only included two studies with over 100 participants; if there was just one trial with 100 participants in each treatment arm reporting an unbiased result, this review would be of much greater use for people with schizophrenia, as well as for clinicians. </p> <p>Future trials need to report any adverse effects, as this was very poorly reported, and of interest to policymakers, more economic data are pivotal. All outcomes in this review were reported in the short term (≤ 6 months), thus we propose that future trials investigate benefits over a longer period of time. We recognise that designing a good‐quality trial requires time, effort, and commitment. </p> <p>Considering the poor quality of the trials included in this review, we have suggested our own outline for a trial in <a href="#CD012844-tbl-0006">Table 3</a>. </p> </section> </section> </section> <div class="table" id="CD012844-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Reviews suggested by excluded trials</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Suggested title or link to existing review</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0031" title="LoewyR , FisherM , MathalonDH , VinogradovS . Interim analyses of a randomized controlled trial of computerized cognitive training in clinical high risk for psychosis. Schizophrenia Bulletin2013;39:S238-9. LoewyR , FisherM , SchlosserDA , BiagiantiB , StuartB , MathalonDH , et al. Intensive auditory cognitive training improves verbal memory in adolescents and young adults at clinical high risk for psychosis. Schizophrenia Bulletin2016;42(Suppl 1):S118-26. NCT00655239. Effectiveness of neuroadaptive cognitive training in adolescents at risk for psychosis. clinicaltrials.gov/ct2/show/NCT00655239 (first received April 9, 2008). ">Loewy 2013</a>; </p> <p><a href="./references#CD012844-bbs2-0026" title="NCT02404194. Targeted cognitive training in clinical high risk (CHR) for psychosis. clinicaltrials.gov/ct2/show/NCT02404194 (first received March 31, 2015). ">Hooker 2019</a>; </p> <p><a href="./references#CD012844-bbs2-0037" title="NCT01619319. Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. ClinicalTrials.gov/show/NCT01619319 (first received June 14, 2012). PiskulicD , BarbatoM , AddingtonJ . Cognitive remediation in young people at clinical high risk of psychosis. Early Intervention in Psychiatry2012;6:89. PiskulicD , BarbatoM , AddingtonJ . Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. Schizophrenia Research2012;136:S245-6. PiskulicD , BarbatoM , LiuL , AddingtonJ . Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. Schizophrenia Research2014;153(Suppl 1):S218. PiskulicD , BarbatoM , LiuL , AddingtonJ . Effects of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Early Intervention in Psychiatry2014;8:86. ">Piskulic 2012</a>; </p> <p><a href="./references#CD012844-bbs2-0014" title="CangasAJ , NavarroN , ParraJMA , OjedaJJ , CangasD , PiedraJA , et al. Stigma-Stop: a serious game against the stigma toward mental health in educational settings. Frontiers in Psychology2017;8:1385. ">Cangas 2017</a>; </p> <p><a href="./references#CD012844-bbs2-0022" title="GyllenstenAL , ForsbergKA . Computerized physical activity training for persons with severe mental illness - experiences from a communal supported housing project. Disability and Rehabilitation: Assistive Technology2017;12(8):780-8. ">Gyllensten 2017</a>; </p> <p><a href="./references#CD012844-bbs2-0030" title="KoikeS , YamaguchiS , OjioY , AndoS . Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype. Psychiatry Research2018;261:264-8. KoikeS , YamaguchiS , OjioY , OhtaK , ShimadaT , WatanabeK , et al. A randomised controlled trial of repeated filmed social contact on reducing mental illness-related stigma in young adults. Epidemiology and Psychiatric Sciences2018;27:199-208. UMIN000012239. An open-label parallel group randomized controlled trial for investigating the efficacy and persistence of internet self-learning and filmed social contact for reducing stigma in the university students. https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013570 (first received 10 November 2013). YamaguchiS , KoikeS , OjioY , ShimadaT , WatanabeKI , AndoS . Filmed social contact v. internet self-learning to reduce mental health-related stigma among university students in Japan: a randomized controlled trial. Early Intervention in Psychiatry2014;8:52. ">Koike 2018</a>; </p> <p><a href="./references#CD012844-bbs2-0038" title="PiskulicD , BarbatoM , LiuL , AddingtonJ . Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Research2015;225(1-2):93-8. ">Piskulic 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with high risk of psychosis, not people with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Video game vs other treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Video games for people at high risk of psychosis</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0010" title="BellMD . Cognitive training to enhance work program outcomes: preliminary findings. Schizophrenia Bulletin2015;41:S302. ">Bell 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="11" valign="top"> <p>People with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Posit Science vs Nintendo BrainAge</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="12" valign="top"> <p>Cognitive training for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0011" title='BellMD , LawsH , PittmanB , JohannesenJK . Comparison of focused cognitive training and portable "brain-games" on functional outcomes for vocational rehabilitation participants. Scientific Reports2018;8(1):1779. NCT00829400. Cognitive training to enhance VA work program outcomes. clinicaltrials.gov/ct2/show/NCT00829400 (first received January 27, 2009). '>Bell 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Posit Science vs Nintendo BrainAge</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0017" title="ChoiKH , KangJ , KimSM , LeeSH , ParkSC , LeeWH , et al. Efficacy of computer assisted cognitive remediation in mid-aged and older inpatients with chronic schizophrenia in Korea. Schizophrenia Bulletin2018;44(Suppl 1):S240-1. ">Choi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive remediation (computer assisted) with psychiatric rehabilitation vs psychiatric rehabilitation </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0020" title="DomenA . The cognition game study. http://isrctn.com/2017. ">Domen 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive training through playing AquaSnap video game vs treatment as usual</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0021" title="FisherM , NahumM , HowardE , RowlandsA , BrandrettB , KermottA , et al. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: an interim report. Psychiatric Rehabilitation Journal2017;40(1):21-32. [PMID: 28368179]">Fisher 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Targeted cognitive training vs social cognition training</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0047" title="ZhangW , ShilukA , RackelmannS , TarasenkoM , ThomasM , BismarkA , et al. The 40-HZ auditory steady-state response: a sensitive and predictive biomarker of perceptual learning during cognitive training. Schizophrenia Bulletin2017;43:S183-4. ">Zhang 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐auditory video games vs targeted cognitive training</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0055" title="NCT01988714. Cognitive remediation of schizophrenia in a community mental health setting. Clinicaltrials.gov/show/NCT01988714 (first received November 20, 2013). ">Vinogradov 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Online auditory and social cognitive training vs free‐choice online cognitive exercises</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0013" title="NCT02584114. Brain effects of memory training in early psychosis. clinicaltrials.gov/ct2/show/NCT02584114 (first received October 22, 2015). ">Buchy 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Memory vs non‐memory training group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0044" title="NCT02782442. Cognitive training delivered remotely to individuals with schizophrenia. clinicaltrials.gov/ct2/show/NCT02782442 (first recieved May 25, 2016). ">Vinogradov 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Online auditory and social cognitive training vs free‐choice online cognitive exercises</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0046" title="ZhangQ , YuanY , SunL , RenQ , ZhangL . The effect of group psychological game therapy on the quality of life of patients with schizophrenia.. Chinese Journal of Health Psychology2014;22(11):1705-8. ">Zhang 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychological play therapy</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0048" title="ZhouY , ZhengY . The clinical effect of team mental games on patients with schizophrenia during rehabilitation. Chinese Prescription Drugs2014;12(6):92-3. ">Zhou 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychological games</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0034" title="NiemanDH , DomenAC , KumarR , HarrisonJ , De HaanL , DenysDA . Cognitive remediation in psychiatric patients with an online cognitive game and assessment tool. European Neuropsychopharmacology2015;25:S344-5. ">Nieman 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OCD, schizophrenia/schizoaffective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monster Valley cognition game vs TAU</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0015" title="CavezianC , Berquand-MerleM , FranckN , DemilyC . Chess self-training for cognitive remediation in schizophrenia. Schizophrenia Research2008;98:53. ">Cavezian 2008</a>; <a href="./references#CD012844-bbs2-0019" title="DemilyC , CavezianC , DesmurgetM , Berquand-MerleM , ChambonV , FranckN . The game of chess enhances cognitive abilities in schizophrenia. Schizophrenia Research2009;107(1):112-3. [PMID: 18995990]">Demily 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>People with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chess playing vs TAU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Non‐video games for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0016" title="ChoiJ , MedaliaA . Intrinsic motivation and learning in a schizophrenia spectrum sample. Schizophrenia Research2010;118(1-3):12-9. ">Choi 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motivational math game vs math game</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0043" title="TurveyAA , MainCJ , McMartneyA . Social activity groups with chronic schizophrenics: the influence of the therapist's behaviour. British Journal of Occupational Therapy1985;48:302-4. ">Turvey 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Playing cards</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0042" title="TorresA , MendezLP , MerinoH , MoranEA . Improving social functioning in schizophrenia by playing the train game. Psychiatric Services (Washington, D.C.)2002;53(7):799-801. [PMID: 12096159]">Torres 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Train Game vs occupational therapy</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0042" title="TorresA , MendezLP , MerinoH , MoranEA . Improving social functioning in schizophrenia by playing the train game. Psychiatric Services (Washington, D.C.)2002;53(7):799-801. [PMID: 12096159]">Torres 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Train Game vs occupational therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Occupational therapy for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0029" title="KellyL . Trivia Psychotica: the Development and Evaluation of an Educational Game for the Revision of Psychotic Disorders in an RMN. Training Programme [Degree in Nursing Dissertation]. University of Ulster, 1992. KellyS . Trivia-psychotica: the development and evaluation of an educational game for the revision of psychiatric disorders in a nurse training programme. Journal of Psychiatric and Mental Health Nursing1995;2(6):366-7. [MEDLINE: 8696789]">Kelly 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse trainees</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trivia Psychotica game vs standard care, not video games</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0062" title="BhoopathiPS , SheoranR . Educational games for mental health professionals. Cochrane Database of Systematic Reviews2006, Issue 2. Art. No: CD001471. [DOI: 10.1002/14651858.CD001471.pub2] [PMID: 16625545]">Bhoopathi 2006</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0009" title="BarnettO . Nonprofessionals in the rehabilitation of mentally disordered sex offenders. Community Mental Health Journal1978;14(2):110-5. [PMID: 699527]">Barnett 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mentally disordered sex offenders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Group encounters vs hobby and game control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Group treatment for mentally disorder sex offenders; games for mentally disorder sex offenders </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>OCD: obsessive–compulsive disorder<br/>TAU: treatment as usual </p> </div> </div> <div class="table" id="CD012844-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Methods</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation: randomised ‐ method described.</p> <p>Allocation concealed ‐ method described.</p> <p>Blinding: none.</p> <p>Duration: 30 minutes, twice a week for 10 weeks with a 3‐, 6‐, and 9‐month follow‐up.</p> <p>Setting: community mental health setting.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis: DSM‐IV Axis I diagnosis of schizophrenia or schizophrenia‐like illnesses.<br/>N = 300.*<br/>Age: 18 to 40.<br/>Sex: any. </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Interventions</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Exergame/non‐exergame** + treatment as usual. N = 150.</p> <p>2. Treatment as usual. N = 150.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning ‐ general: compliance with treatment, CGI ‐ clinically important changes.</p> <p>Functioning ‐ physical: SPPB.<br/>Functioning ‐ social: employed, relationship status.<br/>Adverse effects: relapse, hospitalisation, BPAQ, any recorded adverse effects.<br/>Mental state: PANSS.<br/>Quality of life: QOL.<br/>Economic outcomes: costs of intervention. </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*For binary outcome, for 20% difference in groups, usually about 150 people in each group is needed to achieve adequate power. </p> <p>**We express no preference for which of the broad classes of games should be the focus of a new trial. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BPAQ: Buss‐Perry Aggression Questionnaire<br/>CGI: Clinical Global Impression<br/>DSM: Diagnostic and Statistical Manual of Mental Disorders<br/>PANSS: Positive and Negative Syndrome Scale<br/>QOL: Quality of Life Questionnaire<br/>SPPB: Short Physical Performance Battery </p> </div> </div> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012844-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012844-sec-0008"></div> <div class="table" id="CD012844-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION (plus standard care) for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION for people with schizophrenia (plus standard care) (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> inpatient and outpatient<br/><b>Intervention:</b> video games (commercial non‐exergames)<br/><b>Comparison:</b> cognitive remediation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with cognitive remediation</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (commercial non‐exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ average endpoint score (Strauss Carpenter Outcome Scale)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.42 higher<br/>(0.62 lower to 1.46 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ improved (MCCB, at least 1 domain) ‐ 3‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>773 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>448 per 1000<br/>(263 to 765) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.58<br/>(0.34 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ average endpoint score (SLOF, high = good)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.13 lower<br/>(40.17 lower to 33.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects*: leaving the study early ‐ did not leave ‐ by end of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>232 per 1000<br/>(156 to 342) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96 (0.87 to 1.06)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>395<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*No studies directly reported on adverse effects.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ average endpoint score (PANSS, total, high = poor)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.20 higher<br/>(3.89 lower to 4.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>269<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness: clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported on this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 higher<br/>(0.40 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by 1 ‐ randomisation and concealment of allocation not well described.<br/><sup>2</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol.<br/><sup>3</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals.<br/><sup>4</sup>Indirectness: downgraded by 1 ‐ leaving the study is proxy for adverse effects and may not even represent a negative event/effect. </p> <p>MCCB: (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery<br/>PANSS: Positive and Negative Syndrome Scale<br/>SLOF: Specific Levels of Functioning<br/>QLS: Quality of Life Scale </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012844-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> video games (exergames)<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ average change score (MCCB, increase = good)*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.90 higher<br/>(1.27 lower to 7.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects*: leaving the study early ‐ did not leave</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>765 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>811 per 1000<br/>(574 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.06<br/>(0.75 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*No studies directly reported on adverse effects.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness*: average change VO<sub>2</sub> peak (AF, increase = good) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.82 higher</p> <p>(1.75 higher to 5.89 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ any change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol.<br/><sup>2</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals.<br/><sup>3</sup>Indirectness: downgraded by 1 ‐ leaving the study is proxy for adverse effects and may not even represent a negative event/effect.<br/><sup>4</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol; aerobic fitness is proxy for physical fitness and may not correspond to clinically important change. </p> <p>AF: aerobic fitness<br/>MCCB: (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery<br/>VO<sub>2</sub> peak: peak oxygen uptake </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012844-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> video games (exergames) (plus standard care)<br/><b>Comparison:</b> video games (non‐exergames) (plus standard care) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (non‐exergames)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome. studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effect: any important adverse effect</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness: specific ‐ walking speed ‐ average endpoint (seconds taken to walk 3 metres)* </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 seconds lower<br/>(1.17 lower to 0.17 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊝⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ any change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by 2 ‐ method of randomisation not described; allocation and blinding not described.<br/><sup>2</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol; walking speed is proxy for physical fitness and may not correspond to clinically important change.<br/><sup>3</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012844-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012844-sec-0009"></div> <section id="CD012844-sec-0010"> <h3 class="title" id="CD012844-sec-0010">Description of the condition</h3> <p>Schizophrenia is a psychiatric disorder that affects populations worldwide (<a href="./references#CD012844-bbs2-0115" title="OwenMJ , SawaA , MortensenPB . Schizophrenia. Lancet2016;388(10039):86-97. [PMID: 26777917]">Owen 2016</a>). It is estimated that the median incidence for schizophrenia is 15.2 in every 100,000 people, with a prevalence ratio for males:females of 1.4:1 (<a href="./references#CD012844-bbs2-0105" title="McGrathJ , SahaS , ChantD , WelhamJ . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews2008;30:67-76. [PMID: 18480098]">McGrath 2008</a>). Typical age of onset is late adolescence, which is the time when brain development can be susceptible to onset and development of psychosis (<a href="./references#CD012844-bbs2-0079" title="GogtayN , VyasNS , TestaR , WoodSJ , PantelisC . Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophrenia Bulletin2011;37(3):504-13. [PMID: 21505117]">Gogtay 2011</a>). </p> <p>Compared with the general population, people with schizophrenia have a two‐ to three‐fold higher mortality rate, which translates to a 10‐ to 25‐year life expectancy reduction (<a href="./references#CD012844-bbs2-0097" title="LaursenTM , Munk-OlsenT , VestergaardM . Life expectancy and cardiovascular mortality in persons with schizophrenia. Current Opinion in Psychiatry2012;25(2):83-8. [PMID: 22249081]">Laursen 2012</a>). Suicide is the most common cause of premature death for people with schizophrenia, with a meta‐analysis estimating that 4.9% of people with schizophrenia will commit suicide during their lifetime (<a href="./references#CD012844-bbs2-0116" title="PalmerBA , PankratzVS , BostwickJM . The lifetime risk of suicide in schizophrenia: a reexamination. Archives of General Psychiatry2005;62(3):247-53. [PMID: 15753237]">Palmer 2005</a>), whereas a lifetime prevalence cross‐nationally of suicide attempts in the general population is 2.7% (<a href="./references#CD012844-bbs2-0110" title="NockMK , BorgesG , BrometEJ , AlonsoJ , AngermeyerM , BeautraisA , et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. British Journal of Psychiatry2008;192(2):98-105. [PMID: 18245022]">Nock 2008</a>). </p> <p>Adults with schizophrenia experience an array of symptoms. The 13 core symptoms may be grouped into five broad categories: </p> <p> <ol id="CD012844-list-0001"> <li> <p>positive symptoms (delusion, unusual thought content, hallucinations);</p> </li> <li> <p>negative symptoms (flat affect, emotional withdrawal, self‐neglect, impaired motivation);</p> </li> <li> <p>depressive symptoms (depressive mood, anxiety);</p> </li> <li> <p>cognitive symptoms (lack of attention, disorientation); and</p> </li> <li> <p>behavioural symptoms (hostility, euphoria) (<a href="./references#CD012844-bbs2-0058" title="BakM , van derSpilF , GuntherN , RadstakeS , DelespaulP , vanOsJ . Maastricht Assessment of Coping Strategies (MACS-I): a brief instrument to assess coping with psychotic symptoms. Acta Psychiatrica Scandinavica2001;103(6):453-9. [PMID: 11401660]">Bak 2001</a>). </p> </li> </ol> </p> <p>Antipsychotic medication is the mainstay treatment for the symptoms of schizophrenia, and these medications tend to have a beneficial effect on managing positive symptoms such as delusions, unusual thoughts, and hallucinations (<a href="./references#CD012844-bbs2-0125" title="SuenderhaufC , WalterA , LenzC , LangUE , BorgwardtS . Counter striking psychosis: commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies. Neuroscience and Biobehavioral Reviews2016;68:20-36. [PMID: 27090742]">Suenderhauf 2016</a>). However, negative symptoms, such as anhedonia and social withdrawal, are usually more difficult to manage (<a href="./references#CD012844-bbs2-0125" title="SuenderhaufC , WalterA , LenzC , LangUE , BorgwardtS . Counter striking psychosis: commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies. Neuroscience and Biobehavioral Reviews2016;68:20-36. [PMID: 27090742]">Suenderhauf 2016</a>). The number of people with chronic schizophrenia who do not get an adequate response with medication is around 50% to 60% (<a href="./references#CD012844-bbs2-0132" title="YangCY , LeeTH , LoSC , BecksteadJW . The effects of auditory hallucination symptom management programme for people with schizophrenia: a quasi-experimental design. Journal of Advanced Nursing2015;71(12):2886-97. [PMID: 26283291]">Yang 2015</a>). As a result, people with schizophrenia continue to experience distressing, chronic symptoms (<a href="./references#CD012844-bbs2-0060" title="BauerSM , SchandaH , KarakulaH , Olajossy-HilkesbergerL , RudalevicieneP , OkribelashviliN , et al. Culture and the prevalence of hallucinations in schizophrenia. Comprehensive Psychiatry2011;52(3):319-25. [PMID: 21497227]">Bauer 2011</a>). </p> <p>Other interventions, such as cognitive remediation, are often used as an adjunctive treatment to antipsychotic drugs, incorporating computerised exercises to improve cognitive processes in people with schizophrenia (<a href="./references#CD012844-bbs2-0059" title="BarlatiS , DesteG , De PeriL , AriuC , VitaA . Cognitive remediation in schizophrenia: current status and future perspectives. Schizophrenia Research and Treatment2013;2013:156084. [PMID: 24455253]">Barlati 2013</a>). Video games, whilst being a form of computerised exercises, have also been linked to cognitive benefits (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). </p> </section> <section id="CD012844-sec-0011"> <h3 class="title" id="CD012844-sec-0011">Description of the intervention</h3> <p>We will define video gaming as <i>computerised,</i> <i>electronic manipulation</i> of images forming an <i>interactive, graphically interesting</i> game played using a controller or keyboard on a display monitor. Video gaming is now one of the most popular recreational pastimes (<a href="./references#CD012844-bbs2-0130" title="WittekCT , FinseråsTR , PallesenS , MentzoniRA , HanssD , GriffithsMD , et al. Prevalence and predictors of video game addiction: a study based on a national representative sample of gamers. International Journal of Mental Health and Addiction2016;14(5):672-86.">Wittek 2016</a>). It differs to other similar forms of recreational pastimes such as reading books and watching television due to its interactive elements. Players are not forced to adhere to a game's storyline, they are actively involved in the development of the game and, in turn, the game actively responds to the players' behaviour (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). Games can be played alone, competitively against another person, or with people worldwide using online platforms. Games can be played using consoles (e.g. Xbox, Playstation), computers, or even mobile phones (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). This is the largest entertainment industry in the UK (<a href="./references#CD012844-bbs2-0089" title="HollingdaleJ , GreitemeyerT . The effect of online violent video games on levels of aggression. PLOS ONE2014;9(11):e111790. [PMID: 25391143]">Hollingdale 2014</a>); 25% of Europeans play video games at least once a week (<a href="./references#CD012844-bbs2-0091" title="Ipsos MediaCT. Videogames in Europe: consumer study, 2012. https://www.isfe.eu/wp-content/uploads/2018/11/euro_summary_-_isfe_consumer_study.pdf (accessed prior to 9 October 2017).">Ipsos MediaCT 2012</a>), and 59% of North Americans (<a href="./references#CD012844-bbs2-0092" title="Ipsos MediaCT. The 2014 essential facts about the computer and video game industry. https://time.com/wp-content/uploads/2015/03/esa_ef_2014.pdf (accessed prior to 9 October 2017).">Ipsos MediaCT 2014</a>). Being a constantly improving technology, using serious games for training and educational purposes is also a burgeoning area. In people with psychosis, these types of games greatly improve the adherence to e‐interventions (<a href="./references#CD012844-bbs2-0112" title="O'HanlonP , Aref-AdibG , FonsecaA , Lloyd-EvansB , OsbornD , JohnsonS . Tomorrow's world: current developments in the therapeutic use of technology for psychosis. BJPsych Advances2016;22(5):301-10.">O'Hanlon 2016</a>). The games incorporate 'rewards' or 'extra lives' that can be redeemed daily, thus encouraging much needed engagement with services (<a href="./references#CD012844-bbs2-0112" title="O'HanlonP , Aref-AdibG , FonsecaA , Lloyd-EvansB , OsbornD , JohnsonS . Tomorrow's world: current developments in the therapeutic use of technology for psychosis. BJPsych Advances2016;22(5):301-10.">O'Hanlon 2016</a>). This improvement in adherence is not surprising given that by 21 years of age, the average adolescent is estimated to have played around 10,000 hours of video games (<a href="./references#CD012844-bbs2-0095" title="KuhnS , GleichT , LorenzRC , LindenbergerU , GallinatJ . Playing Super Mario induces structural brain plasticity: gray matter changes resulting from training with a commercial video game. Molecular Psychiatry2014;19(2):265-71. [PMID: 24166407]">Kuhn 2014</a>). </p> </section> <section id="CD012844-sec-0012"> <h3 class="title" id="CD012844-sec-0012">How the intervention might work</h3> <p>There exists a public perception that playing video games promotes intellectual laziness and sedentary lifestyles (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>; <a href="./references#CD012844-bbs2-0085" title="HernandezB , GortmakerSL , ColditzGA , PetersonKE , LairdNM , Parra-CabreraS . Association of obesity with physical activity, television programs and other forms of video viewing among children in Mexico City. International Journal of Obesity and Related Metabolic Disorders1999;23(8):845-54. [PMID: 10490786]">Hernandez 1999</a>; <a href="./references#CD012844-bbs2-0114" title="OwenN , SparlingPB , HealyGN , DunstanDW , MatthewsCE . Sedentary behavior: emerging evidence for a new health risk. Mayo Clinic Proceedings2010;85(12):1138-41. [PMID: 21123641]">Owen 2010</a>), the latter of which is highly prevalent in people with schizophrenia (<a href="./references#CD012844-bbs2-0094" title="KimhyD , KhanS , AyanrouhL , ChangRW , HansenMC , ListerA , et al. Use of active-play video games to enhance aerobic fitness in schizophrenia: feasibility, safety, and adherence. Psychiatric Services (Washington, D.C.)2016;67(2):240-3. [PMID: 26423100]">Kimhy 2016</a>). However, it has been found that these games allow players to develop a wide range of cognitive skills (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). Nevertheless, it has also been demonstrated that whilst video games can promote prosocial outcomes, violent video games can increase aggression (<a href="./references#CD012844-bbs2-0082" title="GreitemeyerT , MuggeDO . Video games do affect social outcomes: a meta-analytic review of the effects of violent and prosocial video game play. Personality &amp; Social Psychology Bulletin2014;40(5):578-89. [PMID: 24458215]">Greitemeyer 2014</a>; <a href="./references#CD012844-bbs2-0089" title="HollingdaleJ , GreitemeyerT . The effect of online violent video games on levels of aggression. PLOS ONE2014;9(11):e111790. [PMID: 25391143]">Hollingdale 2014</a>). Behavioural and magnetic resonance imaging studies have demonstrated that video games have the potential to impact brain plasticity (<a href="./references#CD012844-bbs2-0125" title="SuenderhaufC , WalterA , LenzC , LangUE , BorgwardtS . Counter striking psychosis: commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies. Neuroscience and Biobehavioral Reviews2016;68:20-36. [PMID: 27090742]">Suenderhauf 2016</a>). Video games are easily accessible, and may counteract the limitations of other therapies (e.g. cognitive behavioural therapy). These include a reduction in the number of clinicians properly trained in the approach, limited patient resources, and people choosing not to access mental health services. About 50% of people with schizophrenia in the USA do not receive any treatment (<a href="./references#CD012844-bbs2-0080" title="GottliebJD , RomeoKH , PennDL , MueserKT , ChikoBP . Web-based cognitive-behavioral therapy for auditory hallucinations in persons with psychosis: a pilot study. Schizophrenia Research2013;145(1-3):82-7. [PMID: 23410709]">Gottlieb 2013</a>). Video games could potentially offer relief for people with schizophrenia without the need for professionals, and encourage a greater proportion of the population to engage with services. Furthermore, in discussions with academics in the field, it has been stated that people with schizophrenia have reportedly shown a reduction in delusional thinking and extrapyramidal symptoms following only eight weeks of Internet‐game play (<a href="./references#CD012844-bbs2-0061" title="BavelierD , GreenCS , HanDH , RenshawPF , MerzenichMM , GentileDA . Brains on video games. Nature Reviews. Neuroscience2011;12(12):763-8. [PMID: 22095065]">Bavelier 2011</a>; <a href="./references#CD012844-bbs2-0023" title="HanDH , RenshawPF , SimME , KimJI , ArenellaLS , LyooIK . The effect of internet video game play on clinical and extrapyramidal symptoms in patients with schizophrenia. Schizophrenia Research2008;103(1-3):338-40. [PMID: 18304782]">Han 2008</a>). </p> <p>One way in which video games may be beneficial in treating people with schizophrenia is through distraction, that is the holding or focusing of attention (<a href="./references#CD012844-bbs2-0127" title="TrygstadL , BuccheriR , DowlingG , ZindR , WhiteK , Johnson GriffinJ , et al. Behavioral management of persistent auditory hallucinations in schizophrenia: outcomes from a 10-week course. Journal of the American Psychiatric Nurses Association2002;8(3):84-91.">Trygstad 2002</a>). Due to the suspenseful and pleasurable nature of video games, they have the potential to fully engage a player's attention (<a href="./references#CD012844-bbs2-0125" title="SuenderhaufC , WalterA , LenzC , LangUE , BorgwardtS . Counter striking psychosis: commercial video games as potential treatment in schizophrenia? A systematic review of neuroimaging studies. Neuroscience and Biobehavioral Reviews2016;68:20-36. [PMID: 27090742]">Suenderhauf 2016</a>). We will define distraction as a 'real‐life' action <i>voluntarily</i> taken, which then increases vulnerability to the <i>involuntary</i> distraction from symptoms. </p> <p>The largest problem faced by clinicians is engagement with young people and adolescents. This may be due to young people and adolescents not engaging with the therapies or not recognising that they have a mental health problem (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). Video games not only have the ability to engage adolescents, but also the wider population. In the UK, 37% of the population aged 16 to 49 years described themselves as 'active gamers' (<a href="./references#CD012844-bbs2-0107" title="MorrisG , ForrestR . Wham, sock, kapow! Can Batman defeat his biggest foe yet and combat mental health discrimination? An exploration of the video games industry and its potential for health promotion. Journal of Psychiatric and Mental Health Nursing2013;20(8):752-60. [PMID: 23964592]">Morris 2013</a>). Furthermore, an age breakdown of gamers on average across Europe sees 51% of users below 35 years of age, with 49% of users 35 years or older (<a href="./references#CD012844-bbs2-0091" title="Ipsos MediaCT. Videogames in Europe: consumer study, 2012. https://www.isfe.eu/wp-content/uploads/2018/11/euro_summary_-_isfe_consumer_study.pdf (accessed prior to 9 October 2017).">Ipsos MediaCT 2012</a>). In addition to distraction from symptoms, video gaming may also increase positive attitudes, improve problem solving, and reduce abnormal behaviours (<a href="./references#CD012844-bbs2-0077" title="Fernandez-ArandaF , Jimenez-MurciaS , SantamariaJJ , GunnardK , SotoA , KalapanidasE , et al. Video games as a complementary therapy tool in mental disorders: PlayMancer, a European multicentre study. Journal of Mental Health (Abingdon, England)2012;21(4):364-74. [PMID: 22548300]">Fernandez‐Aranda 2012</a>). </p> <p>Video games are stereotypically perceived to be a static activity. However, 'exergames' are video games that look to promote physical fitness and rehabilitate motor function in various populations. These games allow play whilst incorporating exercise as the game responds to bodily movements. Physical activity is reduced in people with schizophrenia, and exergames improve endurance, motor co‐ordination, flexibility, and balance skills, and hence have the potential to be a robust intervention for people with schizophrenia (<a href="./references#CD012844-bbs2-0067" title="CamposC , MesquitaF , MarquesA . Feasibility and acceptability of an exergame intervention for schizophrenia. Psychology of Sport and Exercise2015;19:50-8.">Campos 2015</a>). </p> <p>Due to a growing interest from several healthcare systems in increasing accessibility of treatment for mental health disorders, implementing these new technologies to treat people with schizophrenia is something that is desired by many (<a href="./references#CD012844-bbs2-0077" title="Fernandez-ArandaF , Jimenez-MurciaS , SantamariaJJ , GunnardK , SotoA , KalapanidasE , et al. Video games as a complementary therapy tool in mental disorders: PlayMancer, a European multicentre study. Journal of Mental Health (Abingdon, England)2012;21(4):364-74. [PMID: 22548300]">Fernandez‐Aranda 2012</a>). If video gaming could be used successfully to provide targeted functional activation changes, it could be a beneficial intervention for people with severe psychiatric disorders such as schizophrenia. Given the majority of the games being targeted at young people, this could provide an added benefit, as it is consistent the typical age of onset of schizophrenia, in late adolescence (<a href="./references#CD012844-bbs2-0079" title="GogtayN , VyasNS , TestaR , WoodSJ , PantelisC . Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophrenia Bulletin2011;37(3):504-13. [PMID: 21505117]">Gogtay 2011</a>). </p> </section> <section id="CD012844-sec-0013"> <h3 class="title" id="CD012844-sec-0013">Why it is important to do this review</h3> <p>We are unsure if commercial games have an effect on the mental well‐being of people in general and of people with schizophrenia in particular. There is concern that they could be detrimental (<a href="./references#CD012844-bbs2-0126" title="TortoleroSR , PeskinMF , BaumlerER , CuccaroPM , ElliottMN , DaviesSL , et al. Daily violent video game playing and depression in preadolescent youth. Cyberpsychology, Behavior and Social Networking2014;17(9):609-15. [PMID: 25007237]">Tortolero 2014</a>). Notwithstanding, video gaming has not only shown possible physiological benefits but also a much needed improvement with engagement of services in people with psychosis (<a href="./references#CD012844-bbs2-0112" title="O'HanlonP , Aref-AdibG , FonsecaA , Lloyd-EvansB , OsbornD , JohnsonS . Tomorrow's world: current developments in the therapeutic use of technology for psychosis. BJPsych Advances2016;22(5):301-10.">O'Hanlon 2016</a>). However, we are also aware that video games can be used as an easy control group to more sophisticated ‐ and expensive ‐ interventions such as cognitive remediation. As with a previous Cochrane Review assessing supportive therapy for people with schizophrenia (<a href="./references#CD012844-bbs2-0065" title="BuckleyLA , MaayanN , Soares-WeiserK , AdamsCE . Supportive therapy for schizophrenia. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD004716. [DOI: 10.1002/14651858.CD004716.pub4]">Buckley 2015</a>), the low‐grade 'control' to many more complex approaches is the main focus of this review. If, as for the 'Supportive therapy for schizophrenia' review (<a href="./references#CD012844-bbs2-0065" title="BuckleyLA , MaayanN , Soares-WeiserK , AdamsCE . Supportive therapy for schizophrenia. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD004716. [DOI: 10.1002/14651858.CD004716.pub4]">Buckley 2015</a>), the control intervention is as effective as the more expensive approaches, simple commercial video games could save an enormous waste of finite resources on researching ostensibly convincing, but ultimately ineffective, interventions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012844-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012844-sec-0014"></div> <p>To review the effects of video games (alone or as an additional intervention) compared to standard care alone or other interventions including, but not limited to, cognitive remediation or cognitive behavioural therapy for people with schizophrenia or schizophrenia‐like illnesses. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012844-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012844-sec-0015"></div> <section id="CD012844-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012844-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) meeting our inclusion criteria and reporting useable data. We considered trials in which randomisation was implied, which we included or excluded once we had carried out a sensitivity analysis (see <a href="#CD012844-sec-0084">Sensitivity analysis</a>). We excluded quasi‐randomised studies, such as those that allocate intervention by alternate days of the week. Where people were given other treatments in addition to video games, we only included the studies if the adjunct treatment was evenly distributed between groups. </p> </section> <section id="CD012844-sec-0018"> <h4 class="title">Types of participants</h4> <p>People with schizophrenia or schizophrenia‐like illnesses, including schizophreniform disorder, schizoaffective disorder, and delusional disorder, by any means of diagnosis. We included trials with participants with schizophrenia or related disorders alongside adults with schizophrenia. However, we excluded any trial that involved 'young people at risk of psychosis', as these people do not have psychosis. </p> <p>To ensure that the information provided was relevant to the current care of people with schizophrenia, we aimed to highlight the current clinical state clearly (acute, early postacute, partial remission, remission), the stage (prodromal, first episode, early illness, persistent), and whether the studies primarily focused on people with particular problems (e.g. negative symptoms, treatment‐resistant illnesses). </p> </section> <section id="CD012844-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We compared video games versus standard care alone or other psychological treatments.</p> <section id="CD012844-sec-0020"> <h5 class="title">1. Video games</h5> <p>"A video game is an electronic game that involves interaction with a user interface to generate visual feedback to a video device such as TV screen or computer monitor [...] it implies any type of display device that can produce two‐ or three‐dimensional images" (<a href="https://en.wikipedia.org/wiki/Video_game" target="_blank">en.wikipedia.org/wiki/Video_game</a>), and an exergame "relies on technology that tracks body movement or reaction" (<a href="https://en.wikipedia.org/wiki/Exergaming" target="_blank">en.wikipedia.org/wiki/Exergaming</a>). </p> <p>We were interested in using commercial video games, played alone, co‐operatively, or competitively, using a console (e.g. Xbox, Playstation), computer, or mobile phone. To be considered 'video gaming', the games would have had to include an interactive element, but we also included games that were simply described as such and did not clearly specify the level of interaction. With players not adhering to a set storyline, but they must be actively engaged in the development of the story, and the video game in turn responds to the player's behaviour (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). </p> <p>We included any intervention that called itself a 'video' or 'computer' game. Additionally, we included 'exergames' as a form of video game if the game is interactive and responds to the player's actions. However, we did not include virtual reality as a form of video gaming, as this is the focus of another recent Cochrane Review (<a href="./references#CD012844-bbs2-0106" title="MoazzenM , ShokranehF . Avatar therapy for schizophrenia or related disorders. Cochrane Database of Systematic Reviews2015, Issue 9. Art. No: CD011898. [DOI: 10.1002/14651858.CD011898]">Moazzen 2015</a>; <a href="./references#CD012844-bbs2-0056" title="AaliG , KariotisT , ShokranehF . Avatar Therapy for people with schizophrenia or related disorders. Cochrane Database of Systematic Reviews2020, Issue 5. Art. No: CD011898. [DOI: 10.1002/14651858.CD011898.pub2]">Aali 2020</a>). We also excluded 'serious games', being those designed for a primary purpose other than entertainment, such as a primary purpose of developing cognitive skills (<a href="./references#CD012844-bbs2-0072" title="DjaoutiD , AlvarezJ , JesselJ . Classifying serious games: the G/P/S model. In: FeliciaP , editors(s). Handbook of Research on Improving Learning and Motivation through Educational Games: Multidisciplinary Approaches. IGI Global, 2011.">Djaouti 2011</a>). </p> <p>We accepted studies that compared the effects of two video games against each other (e.g. exergames versus non‐exergames). </p> <p>We envisaged that the video games would be given alongside the standard professional care that people with schizophrenia would receive. </p> </section> <section id="CD012844-sec-0021"> <h5 class="title">2. Standard care alone</h5> <p>The standard care that the person normally would receive had they not participated in the trial, including, but not limited to, medication and hospitalisation. </p> </section> <section id="CD012844-sec-0022"> <h5 class="title">3. Cognitive remediation</h5> <p>We considered a cognitive remediation to be an intervention that aims to improve any cognitive domains, such as: speed of processing, attention/vigilance, working memory, verbal learning and memory, visual learning and memory, reasoning and problem solving, social cognition (<a href="./references#CD012844-bbs2-0111" title="NuechterleinKH , BarchDM , GoldJM , GoldbertTE , GreenMF , HeatonRK . Identification of separable cognitive factors in schizophrenia. Schizophrenia Research2004;72(1):29-39. [DOI: 10.1016/j.schres.2004.09.007] [PMID: 15531405]">Nuechterlein 2004</a>), and meta‐cognition. </p> <p>See <a href="#CD012844-sec-0224">Differences between protocol and review</a>. </p> </section> <section id="CD012844-sec-0023"> <h5 class="title">4. Other psychological treatments</h5> <p>Including, but not limited to, cognitive behavioural therapy, psychodynamic psychotherapy, or problem‐solving therapy. </p> </section> </section> <section id="CD012844-sec-0024"> <h4 class="title">Types of outcome measures</h4> <p>We divided all outcomes into short term (less than six months), medium term (six to 12 months), and long term (over 12 months). </p> <p>We sought to report binary outcomes recording clear and clinically meaningful degrees of change (e.g. global impression of much improved, or more than 50% improvement on a rating scale defined within the trials). Thereafter, we listed other binary outcomes and then those that were continuous. </p> <section id="CD012844-sec-0025"> <h5 class="title">Primary outcomes</h5> <section id="CD012844-sec-0026"> <h6 class="title">1. Functioning</h6> <p>1.1 General: clinically important change in general functioning ‐ as defined by study, including working ability.<br/>1.2 Specific ‐ cognitive: clinically important change in cognitive functioning ‐ as defined by study.<br/>1.3 Specific ‐ social: clinically important change in social functioning ‐ as defined by study. </p> </section> <section id="CD012844-sec-0027"> <h6 class="title">2. Adverse effects</h6> <p>2.1 At least one important adverse effect.</p> </section> </section> <section id="CD012844-sec-0028"> <h5 class="title">Secondary outcomes</h5> <section id="CD012844-sec-0029"> <h6 class="title">1. Functioning</h6> <p>1.1 General: any change in general functioning ‐ as defined by study, including working ability.<br/>1.2 Specific ‐ cognitive: any change in cognitive functioning ‐ as defined by study.<br/>1.3 Specific ‐ social: mean endpoint or change score on social functioning scale.<br/>1.4 Specific ‐ social: any change in social functioning ‐ as defined by study, e.g. social skills. </p> </section> <section id="CD012844-sec-0030"> <h6 class="title">2. Adverse effects</h6> <p>2.1 Any change in adverse effects: general/specific.<br/>2.2 Very serious event (e.g. death, serious self‐harm, suicide).<br/>2.3 Any change in specific adverse effects (e.g. repetitive strain injury, aggression). </p> </section> <section id="CD012844-sec-0031"> <h6 class="title">3. Mental state</h6> <p>3.1 Clinically important change in general mental state ‐ as defined by study.<br/>3.2 Mean endpoint or change score on general mental state scale.<br/>3.3 Clinically important change in specific symptoms ‐ as defined by study (positive, negative, affective, cognitive symptoms of schizophrenia). </p> </section> <section id="CD012844-sec-0032"> <h6 class="title">4. Physical fitness</h6> <p>4.1 Clinically important change in overall physical fitness ‐ as defined by study.<br/>4.2 Mean change score in overall physical fitness.<br/>4.3 Clinically important change in specific aspects of physical fitness ‐ as defined by study.<br/>4.4 Mean change scores in specific aspects of physical fitness. </p> </section> <section id="CD012844-sec-0033"> <h6 class="title">5. Global state</h6> <p>5.1 Clinically important change in global state (clinical response as defined by study, e.g. global impression of much improved, or more than 50% improvement on a rating scale).<br/>5.2 Relapse ‐ as defined by study.<br/>5.3 Mean endpoint or change score on general global state scale. </p> </section> <section id="CD012844-sec-0034"> <h6 class="title">6. Leaving the study early</h6> <p>6.1 For any reason.<br/>6.2 Due to inefficacy.<br/>6.3 Due to adverse effect. </p> </section> <section id="CD012844-sec-0035"> <h6 class="title">7. Quality of life</h6> <p>7.1 Any change in overall quality of life ‐ as defined by study.<br/>7.2 Mean endpoint or change score on quality of life scale.<br/>7.3 Any change in specific aspects of quality of life ‐ as defined by study.<br/>7.4 Mean endpoint or change score on specific aspects of quality of life scale. </p> </section> <section id="CD012844-sec-0036"> <h6 class="title">8. Behaviour</h6> <p>8.1 Any change in general behaviour ‐ as defined by study.<br/>8.2 Mean endpoint or change score on general behaviour scale.<br/>8.3 Any change in specific aspects of behaviour ‐ as defined by study (e.g. aggression, violence).<br/>8.4 Mean endpoint or change on specific aspects of behaviour scale. </p> </section> <section id="CD012844-sec-0037"> <h6 class="title">9. Economic outcomes</h6> <p>9.1 Costs due to treatment, as defined by study.<br/>9.2 Total direct and indirect costs.<br/>9.3 Mean change in total cost of medical and mental health care. </p> </section> <section id="CD012844-sec-0038"> <h6 class="title">'Summary of findings' table</h6> <p>We used the GRADE approach to interpret findings (<a href="./references#CD012844-bbs2-0121" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a>), and <a href="http://community.cochrane.org/tools/review-production-tools/gradepro-gdt" target="_blank">GRADEpro GDT</a> to export data from our review to create a 'Summary of findings' table. These tables provide outcome‐specific information concerning the overall quality of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes rated as important to patient care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' table. </p> <p> <ol id="CD012844-list-0002"> <li> <p>Functioning ‐ general: clinically important change in general functioning ‐ as defined by study, including working ability. </p> </li> <li> <p>Functioning ‐ specific ‐ cognitive: clinically important change in cognitive functioning ‐ as defined by study. </p> </li> <li> <p>Functioning ‐ specific ‐ social: clinically important change in social functioning ‐ as defined by study. </p> </li> <li> <p>Adverse effect: at least one important adverse effect.</p> </li> <li> <p>Mental state: overall ‐ clinically important change in mental state ‐ as defined by study. </p> </li> <li> <p>Physical fitness: clinically important change in physical fitness ‐ as defined by study. </p> </li> <li> <p>Quality of life: overall ‐ any change in quality of life ‐ as defined by study.</p> </li> </ol> </p> <p>If data were not available for these prespecified outcomes but were available for ones that were similar, we presented the closest outcome available, but took this into account when grading the finding. </p> </section> </section> </section> </section> <section id="CD012844-sec-0039"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012844-sec-0040"> <h4 class="title">Electronic searches</h4> <section id="CD012844-sec-0041"> <h5 class="title">Cochrane Schizophrenia Group's Study‐Based Register of Trials</h5> <p>On 31 March 2017 and 23 August 2018 the Information Specialist searched the register using the following search strategy: </p> <p>*Game* in Intervention Field of STUDY</p> <p>In such study‐based register, searching the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD012844-bbs2-0122" title="ShokranehF , AdamsCE . Study-based registers of randomized controlled trials: starting a systematic review with data extraction or meta-analysis. BioImpacts2017;7(4):209-17. [DOI: 10.15171/bi.2017.25]">Shokraneh 2017</a>; <a href="./references#CD012844-bbs2-0123" title="ShokranehF , AdamsCE . Gallstone, snake venom and witchcraft for schizophrenia: the challenges of classifying [schizophrenia] trials. Evidence-Based Medicine2018;23(Suppl 1):A18. [DOI: 10.1136/bmjebm-2018-111024.36]">Shokraneh 2018</a>). </p> <p>This register is compiled by systematic searches of major resources (Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, AMED (Allied and Complementary Medicine), BIOSIS, CINAHL (Cumulative Index to Nursing and Allied Health Literature), PsycINFO, PubMed, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform) and their monthly updates, ProQuest Dissertations and Theses A&amp;I and its quarterly update, Chinese databases (CBM (Chinese Biomedical Literature Database), CNKI (China National Knowledge Infrastructure), and Wanfang) and their annual updates, handsearches, grey literature, and conference proceedings (see <a href="http://schizophrenia.cochrane.org/register-trials" target="_blank">Group's website</a>). There is no language, date, document type, or publication status limitations for inclusion of records into the register. </p> <p>The Information Specialist performed a further update search on 8 August 2019, employing the same strategy. </p> </section> </section> <section id="CD012844-sec-0042"> <h4 class="title">Searching other resources</h4> <section id="CD012844-sec-0043"> <h5 class="title">1. Reference searching</h5> <p>We inspected references of all included studies for further relevant studies.</p> </section> <section id="CD012844-sec-0044"> <h5 class="title">2. Personal contact</h5> <p>Where additional information regarding relevant studies was required, we contacted the first author. </p> </section> </section> </section> <section id="CD012844-sec-0045"> <h3 class="title" id="CD012844-sec-0045">Data collection and analysis</h3> <section id="CD012844-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Review authors (JL, GH, MF, AZB, MR) independently inspected the citations from the searches and identified relevant abstracts; MV independently re‐inspected a random 20% sample of these abstracts to ensure reliability of selection. Where disputes arose, the full report was acquired for a more detailed scrutiny. Review authors (JL, GH, MF, AZB) then obtained and inspected the full reports of the abstracts or reports meeting the review criteria. MV re‐inspected a random 20% of these full reports to ensure reliability of selection. MR inspected citations from the August 2019 update search, and subsequently re‐inspected all included and ongoing studies and ensured that they met inclusion criteria, amending as necessary. Where it was not possible to resolve disagreement by discussion, we would attempt to contact the authors of the study concerned for clarification. </p> </section> <section id="CD012844-sec-0047"> <h4 class="title">Data extraction and management</h4> <section id="CD012844-sec-0048"> <h5 class="title">1. Extraction</h5> <p>Review authors (JL, GH, MF, AZB) independently extracted data from all included studies. In addition, to ensure reliability, MV independently extracted data from a random sample of these studies, comprising 10% of the total. MR subsequently re‐checked data extraction from all included studies, and amended as necessary. We attempted to extract data presented only in graphs and figures whenever possible, but only included this information if two review authors independently obtained the same result. If studies were multicentre, then where possible, data were extracted relevant to each centre. Any disagreements were discussed by JL and GH and documented. If necessary, JL, GH, MF, and AZB would have attempted to contact authors through an open‐ended request to obtain missing information or for clarification. MV helped clarify issues regarding any remaining problems, and these final decisions were documented. </p> </section> <section id="CD012844-sec-0049"> <h5 class="title">2. Management</h5> <section id="CD012844-sec-0050"> <h6 class="title">2.1. Forms</h6> <p>We extracted data onto standard, pre‐designed, simple forms.</p> </section> <section id="CD012844-sec-0051"> <h6 class="title">2.2. Scale‐derived data</h6> <p>We included continuous data from rating scales only if:</p> <p> <ol id="CD012844-list-0003"> <li> <p>the psychometric properties of the measuring instrument had been described in a peer‐reviewed journal (<a href="./references#CD012844-bbs2-0103" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249-52.">Marshall 2000</a>); and </p> </li> <li> <p>the measuring instrument had not been written or modified by one of the trialists for that particular trial; </p> </li> <li> <p>the instrument should be a global assessment of an area of functioning and not subscores which are not, in themselves, validated or shown to be reliable. However, there are exceptions: we included subscores from mental state scales measuring positive and negative symptoms of schizophrenia. </p> </li> </ol> </p> <p>Ideally the measuring instrument should either be a self‐report or completed by an independent rater or relative (not the therapist). We realise that this is often not reported clearly (<a href="#CD012844-sec-0091">Description of studies</a>). </p> <p>We noted if this was the case or not.</p> </section> <section id="CD012844-sec-0052"> <h6 class="title">2.3. Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data: change data can remove a component of between‐person variability from the analysis; however, calculation of change needs two assessments (baseline and endpoint), which can be difficult to obtain in unstable and difficult‐to‐measure conditions such as schizophrenia. We primarily used endpoint data, only using change data if endpoint data were not available. If necessary, we would have combined endpoint and change data in the analysis, as we prefer using mean differences (MDs) to standardised mean differences (SMDs) (<a href="./references#CD012844-bbs2-0070" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>). </p> </section> <section id="CD012844-sec-0053"> <h6 class="title">2.4. Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the problems of applying parametric tests to non‐parametric data, we applied the following standards to relevant continuous data before inclusion. </p> <p>For endpoint data from studies including fewer than 200 participants:</p> <p> <ol id="CD012844-list-0004"> <li> <p>when a scale started from the ﬁnite number zero, we subtracted the lowest possible value from the mean, and divided this by the standard deviation (SD). If this value was lower than one, it strongly suggested that the data were skewed and we excluded these data. If this ratio was higher than one but less than two, it suggested that the data were skewed: we entered these data and tested whether their inclusion or exclusion would change the results substantially. Finally, if the ratio was larger than two, we included these data, because it was less likely that they were skewed (<a href="./references#CD012844-bbs2-0057" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200.">Altman 1996</a>; <a href="./references#CD012844-bbs2-0087" title="HigginsJPT , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>); </p> </li> <li> <p>if a scale started from a positive value (such as the Positive and Negative Syndrome Scale (PANSS), which can have values from 30 to 210) (<a href="./references#CD012844-bbs2-0093" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda (NY): Multi-Health Systems, 1986.">Kay 1986</a>), we modified the calculation described above to take the scale starting point into account. In these cases, skewed data are present if 2 SD &gt; (S ‐ S<sub>min</sub>), where S is the mean score and S<sub>min</sub> is the minimum score. </p> </li> </ol> </p> <p>Please note: we would have entered all relevant data from studies of more than 200 participants in the analysis irrespective of the above rules, because skewed data pose less of a problem in large studies. However, we did not include any studies containing more than 200 participants. We also would have entered all relevant change data, as when continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to determine whether data are skewed. </p> </section> <section id="CD012844-sec-0054"> <h6 class="title">2.5. Common measurement</h6> <p>To facilitate comparison between trials, where relevant, we would have converted variables that can be reported in different metrics, such as days in hospital (mean days per year, per week, or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD012844-sec-0055"> <h6 class="title">2.6. Conversion of continuous to binary</h6> <p>Where possible, we would have converted outcome measures to dichotomous data. This can be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD012844-bbs2-0113" title="OverallJE , GorhamDR . The Brief Psychiatric Rating Scale. Psychological Reports1962;10:799-812.">Overall 1962</a>), or the PANSS (<a href="./references#CD012844-bbs2-0093" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda (NY): Multi-Health Systems, 1986.">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD012844-bbs2-0099" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?Schizophrenia Research2005;79(2-3):231-8. [PMID: 15982856]">Leucht 2005</a>; <a href="./references#CD012844-bbs2-0100" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry2005;187:366-71. [PMID: 16199797]">Leucht 2005a</a>). If data based on these thresholds were not available, we would use the primary cut‐off presented by the original authors. </p> </section> <section id="CD012844-sec-0056"> <h6 class="title">2.7. Direction of graphs</h6> <p>Where possible, we entered data so that the area to the right of the line of no effect indicates a favourable outcome for video games. Where keeping to this made it impossible to avoid outcome titles with clumsy double‐negatives (e.g. 'not unimproved'), we reported data where the right of the line indicates an unfavourable outcome and noted this in the relevant graphs. </p> </section> </section> </section> <section id="CD012844-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors (JL, GH, MF, AZB, and MR) independently assessed risk of bias using criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012844-bbs2-0088" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011a</a>). This set of criteria is based on evidence of associations between potential overestimation of effect and the level of risk of bias of the article that may be due to aspects of sequence generation, allocation concealment, blinding, incomplete outcome data, and selective reporting, or the way in which these 'domains' are reported. </p> <p>If the raters disagreed, we made the final rating by consensus with the involvement of MV. Where inadequate details of randomisation and other characteristics of trials were provided, we attempted to contact the authors of the studies to obtain the additional information. We reported non‐concurrence in risk of bias assessment, but any disputes arising regarding the category to which a trial was to be allocated were resolved by discussion. </p> <p>We noted the level of risk of bias in the text of the review, 'Risk of bias' graph, 'Risk of bias' summary, and the 'Summary of findings' table/s. </p> </section> <section id="CD012844-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012844-sec-0059"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI), as it has been shown that RR is more intuitive than odds ratios (<a href="./references#CD012844-bbs2-0064" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Aperçu sur la problématique des indices d'efficacité thérapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405-11. [PMID: 10667106]">Boissel 1999</a>), and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD012844-bbs2-0069" title="DeeksJ . Issues in the selection for meta-analyses of binary data. In: 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town, South Africa. Cape Town: The Cochrane Collaboration, 2000.">Deeks 2000</a>). Although the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH), with their CIs, are intuitively attractive to clinicians, they are problematic to calculate and interpret in meta‐analyses (<a href="./references#CD012844-bbs2-0090" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27-30. [PMID: 19438480]">Hutton 2009</a>). For binary data presented in the 'Summary of findings' table/s, where possible, we would have calculated illustrative comparative risks. </p> </section> <section id="CD012844-sec-0060"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we estimated MD between groups. We preferred not to calculate effect size measures (SMD). However, if scales of very considerable similarity were used, we presumed there was a small difference in measurement, and calculated effect size and transformed the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD012844-sec-0061"> <h4 class="title">Unit of analysis issues</h4> <section id="CD012844-sec-0062"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Authors often fail to account for intraclass correlation in clustered studies, leading to a unit of analysis error whereby P values are spuriously low, CIs unduly narrow, and statistical significance overestimated (<a href="./references#CD012844-bbs2-0071" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623-9.">Divine 1992</a>). This causes type I errors (<a href="./references#CD012844-bbs2-0063" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315(7108):600.">Bland 1997</a>; <a href="./references#CD012844-bbs2-0083" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876-83.">Gulliford 1999</a>). </p> <p>Where clustering was incorporated into the analysis of primary studies, we presented these data as if from a non‐cluster‐randomised study, but adjusted for the clustering effect. </p> <p>Where clustering was not accounted for in primary studies, we presented data in a table, with an * symbol to indicate the presence of a probable unit of analysis error. We attempted to contact first authors of studies to obtain intraclass correlation coefficients (ICC) for their clustered data, and adjusted for this using accepted methods (<a href="./references#CD012844-bbs2-0083" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876-83.">Gulliford 1999</a>). </p> <p>We have sought statistical advice and been advised that the binary data from cluster trials presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC: thus, design effect = 1 + (m ‐ 1) × ICC (<a href="./references#CD012844-bbs2-0073" title="DonnerA , KlarN . Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21(19):2971-80.">Donner 2002</a>). If the ICC was not reported, we assumed it to be 0.1 (<a href="./references#CD012844-bbs2-0128" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii-92.">Ukoumunne 1999</a>). </p> <p>If cluster studies were appropriately analysed and ICCs and relevant data documented in the report taken into account, synthesis with other studies would have been possible using the generic inverse variance technique. </p> </section> <section id="CD012844-sec-0063"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. This occurs if an effect (e.g. pharmacological, physiological, or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, participants can differ significantly from their initial state at entry to the second phase, despite a washout phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD012844-bbs2-0076" title="ElbourneD , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>). As both carry‐over and unstable conditions are very likely in severe mental illness, we would only use data from the first phase of cross‐over studies. </p> </section> <section id="CD012844-sec-0064"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involved more than two treatment arms, we would present the additional treatment arms in comparisons if relevant. If data were binary, we would simply add these and combine within the two‐by‐two table. If the data were continuous, we would combine data following the formula in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012844-bbs2-0087" title="HigginsJPT , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Where additional treatment arms were not relevant, we would not reproduce these data. </p> </section> </section> <section id="CD012844-sec-0065"> <h4 class="title">Dealing with missing data</h4> <section id="CD012844-sec-0066"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, data must lose credibility (<a href="./references#CD012844-bbs2-0131" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El-SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin (London, England)2009;33(7):254-7.">Xia 2009</a>). We chose that, for any particular outcome, should more than 50% of data be unaccounted for, we would not reproduce these data or use them within analyses. However, if more than 50% of participants in one arm of a study were lost, but the total loss was less than 50%, we would address this within the 'Summary of findings' table/s by downgrading quality. Finally, we also downgraded quality within the 'Summary of findings' table/s when the loss was 25% to 50% in total. </p> </section> <section id="CD012844-sec-0067"> <h5 class="title">2. Binary</h5> <p>Where attrition for a binary outcome was between 0% and 50% and these data were not clearly described, we presented data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat (ITT) analysis). Participants leaving the study early were all assumed to have the same rates of negative outcome as participants who completed, with the exception of the outcome of death and adverse effects. For these outcomes, the rate of participants who stayed in the study (in that particular arm of the trial) would be used for participants who did not. We undertook a sensitivity analysis testing how prone the primary outcomes were to change when data only from people who completed the study to that point were compared to the ITT analysis using the above assumptions. </p> </section> <section id="CD012844-sec-0068"> <h5 class="title">3. Continuous</h5> <section id="CD012844-sec-0069"> <h6 class="title">3.1. Attrition</h6> <p>We used data where attrition for a continuous outcome was between 0% and 50%, and data only from people who completed the study to that point were reported. </p> </section> <section id="CD012844-sec-0070"> <h6 class="title">3.2. Standard deviations</h6> <p>If SDs were not reported, we would try to obtain the missing values from the authors. If these were not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and CIs available for group means, and either P value or t value available for differences in mean, we could calculate SDs according to the rules described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012844-bbs2-0087" title="HigginsJPT , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). When only the SE was reported, we calculated SDs using the formula SD = SE × √(n). The <i>Cochrane Handbook for Systematic Reviews of Interventions</i> presents detailed formulae for estimating SDs from P, t, or F values; CIs; ranges; or other statistics (<a href="./references#CD012844-bbs2-0087" title="HigginsJPT , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). If these formulae did not apply, we would calculate the SDs according to a validated imputation method which is based on the SDs of the other included studies (<a href="./references#CD012844-bbs2-0078" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7-10.">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study's outcome and thus to lose information. Nevertheless, we examined the validity of the imputations in a sensitivity analysis that excludes imputed values. </p> </section> <section id="CD012844-sec-0071"> <h6 class="title">3.3. Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers; other trials use the method of last observation carried forward (LOCF); whilst more recently, methods such as multiple imputation or mixed‐effects models for repeated measurements (MMRM) have become more of a standard. While multiple imputation or mixed‐effects model methods seem to be somewhat better than LOCF (<a href="./references#CD012844-bbs2-0098" title="LeonAC , MallinckrodtCH , Chuang-SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001-5. [PMID: 16905632]">Leon 2006</a>), we consider that the high percentage of participants leaving the studies early and differences between groups in their reasons for doing so is often the core problem in randomised schizophrenia trials. We would therefore not exclude studies based on the statistical approach used. However, by preference, we would use the more sophisticated approaches, that is we would prefer to use MMRM or multiple imputation to LOCF, and we would only present completer analyses if some type of ITT data were not available at all. Moreover, we would address this issue in the item 'incomplete outcome data' of the 'Risk of bias' tool. </p> </section> </section> </section> <section id="CD012844-sec-0072"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD012844-sec-0073"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for participants who were clearly outliers or situations that we had not predicted would arise and, where these were found, discussed such situations or participant groups. </p> </section> <section id="CD012844-sec-0074"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods that we had not predicted would arise and discussed any such methodological outliers. </p> </section> <section id="CD012844-sec-0075"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD012844-sec-0076"> <h6 class="title">3.1. Visual inspection</h6> <p>We inspected graphs visually to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD012844-sec-0077"> <h6 class="title">3.2. Employing the I² statistic</h6> <p>We investigated heterogeneity between studies by considering the I² statistic alongside the Chi² P value. The I² statistic provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD012844-bbs2-0086" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). The importance of the observed value of the I² statistic depends on the magnitude and direction of effects and the strength of evidence for heterogeneity (e.g. P value from Chi² test, or a CI for the I² statistic). We would interpret an I² statistic estimate of 50% or greater and accompanied by a statistically significant Chi² statistic as evidence of substantial heterogeneity, as described in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012844-bbs2-0070" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>). When we found substantial levels of heterogeneity in the primary outcome, we explored reasons for heterogeneity (<a href="#CD012844-sec-0080">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD012844-sec-0078"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD012844-bbs2-0075" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>), as described in Chapter 10 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012844-bbs2-0124" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Sterne 2011</a>). We are aware that funnel plots may be useful in investigating reporting biases, but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there are 10 or fewer studies, or where all studies were of similar size. In future updates, where funnel plots are possible, we will seek statistical advice on their interpretation. </p> </section> <section id="CD012844-sec-0079"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us, and the random‐effects model takes into account differences between studies, even if there is no statistically significant heterogeneity. However, a disadvantage of the random‐effects model is that it puts added weight onto small studies, which are often the most biased studies. Depending on the direction of effect, these studies can either inflate or deflate the effect size. We used a fixed‐effect model for all analyses. </p> </section> <section id="CD012844-sec-0080"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD012844-sec-0081"> <h5 class="title">1. Subgroup analyses</h5> <section id="CD012844-sec-0082"> <h6 class="title">1.1. Primary outcomes</h6> <p>We did not conduct a subgroup analysis as we did not anticipate sufficient power to carry it out. </p> </section> </section> <section id="CD012844-sec-0083"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>We reported if inconsistency was high. We first investigated whether data had been entered correctly. Secondly, if data were correct, we inspected the graph visually and removed outlying studies successively to see if homogeneity was restored. We decided that should this occur with data contributing to the summary finding of no more than 10% of the total weighting, we would present data. If not, we would not pool these data and would discuss any issues. We know of no supporting research for this 10% cut‐off but investigated use of prediction intervals as an alternative to this unsatisfactory state. </p> <p>When unanticipated clinical or methodological heterogeneity was obvious, we would simply state hypotheses regarding this for future reviews or versions of this review. We did not anticipate undertaking analyses relating to this. </p> </section> </section> <section id="CD012844-sec-0084"> <h4 class="title">Sensitivity analysis</h4> <section id="CD012844-sec-0085"> <h5 class="title">1. Implication of randomisation</h5> <p>We had hoped to include trials in a sensitivity analysis if they were described in some way that implied randomisation. For primary outcomes, if the inclusion of these trials had not resulted in a substantive difference, they would have remained in the analyses. If their inclusion had resulted in clinical, but not necessarily statistically significant differences, we would have not added data from these lower‐quality studies to the results of the higher‐quality trials, but presented these data within a subcategory. </p> </section> <section id="CD012844-sec-0086"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions have to be made regarding people lost to follow‐up (see <a href="#CD012844-sec-0065">Dealing with missing data</a>), we, for the primary outcomes, would have compared the findings of the primary outcomes when we used our assumption compared with completer data only. If there had been a substantial difference, we would have reported the results and discussed them, but continued to employ our assumption. </p> <p>Should assumptions have had to be made regarding missing SD data (see <a href="#CD012844-sec-0065">Dealing with missing data</a>), we would have compared the findings of primary outcomes when we used our assumption compared with completer data only. We would have undertaken a sensitivity analysis to test how prone results are to change when completer data only are compared to the imputed data using the above assumption. If there had been a substantial difference, we would have reported the results and discussed them, but continued to employ our assumption. </p> </section> <section id="CD012844-sec-0087"> <h5 class="title">3. Risk of bias</h5> <p>We had hoped to analyse the effects of excluding trials that are at high risk of bias across one or more of the 'Risk of bias' domains (see <a href="#CD012844-sec-0057">Assessment of risk of bias in included studies</a>) for the meta‐analysis of the primary outcomes. If exclusion of trials at high risk of bias had not altered the direction of effect or the precision of the effect estimates substantially, then we would have included relevant data from these trials. </p> </section> <section id="CD012844-sec-0088"> <h5 class="title">4. Imputed values</h5> <p>We would have undertaken a sensitivity analysis to assess the effects of including data from trials where we use imputed values for ICC in calculating the design effect in cluster‐randomised trials. </p> </section> <section id="CD012844-sec-0089"> <h5 class="title">5. Fixed‐effect and random‐effects models</h5> <p>We synthesised data using a fixed‐effect model; however, we also wished to synthesise data for the primary outcomes using a random‐effects model to evaluate whether this altered the significance of the results. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012844-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012844-sec-0090"></div> <section id="CD012844-sec-0091"> <h3 class="title">Description of studies</h3> <p>For details see <a href="./references#CD012844-sec-0226" title="">Characteristics of included studies</a>, <a href="./references#CD012844-sec-0227" title="">Characteristics of excluded studies</a>, and <a href="./references#CD012844-sec-0228" title="">Characteristics of ongoing studies</a>. </p> <section id="CD012844-sec-0092"> <h4 class="title">Results of the search</h4> <p>The results of our searches are also shown in <a href="#CD012844-fig-0001">Figure 1</a>. The original search produced 118 reports. Following inspection of abstracts and, where required, full papers, we excluded 60 reports of 41 studies with reasons, and included 49 reports of seven studies in the review. We also identified nine reports of seven ongoing studies that may provide further data in future updates of this review. </p> <div class="figure" id="CD012844-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram for 2018 and 2019 searches." data-id="CD012844-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram for 2018 and 2019 searches.</p> </div> </div> </div> </section> <section id="CD012844-sec-0093"> <h4 class="title">Included studies</h4> <section id="CD012844-sec-0094"> <h5 class="title">1. Methods</h5> <p>All included studies were parallel, randomised controlled trials. Five of the included studies disclosed their method of randomisation. Two studies used a random number generator (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>; <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a>); two studies used stratified randomisation (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>); and one study used a computer‐generated randomisation list drawn up by a statistician (<a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>). Two included studies did not state a method of randomisation (<a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). None of the included studies described a method of allocation concealment. Blinding was generally well‐reported, with one study double‐blind and five single‐blind. One study did not specify any method of blinding (<a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). </p> </section> <section id="CD012844-sec-0095"> <h5 class="title">2. Study duration</h5> <p>Study duration across the seven included trials varied: the shortest was <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>, where across six weeks participants spent a total of three hours in the intervention, whilst the longest was <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>, where over 12 weeks a total of 36 hours was spent in the intervention. The most common study duration was 12 weeks (<a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>). </p> </section> <section id="CD012844-sec-0096"> <h5 class="title">3. Settings</h5> <p>Only one study reported that they were focused on inpatients (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>), and one study stated that participants from mental health treatment settings were involved (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>). The remaining studies either involved clinically stable patients or outpatients, or did not specify. The included studies were conducted in Australia, China, Spain, and the USA. </p> </section> <section id="CD012844-sec-0097"> <h5 class="title">4. Participants</h5> <p>The total number of participants in the included studies was 468 (7 different trials that took place between 2009 and 2018). Study sizes varied from 32 participants to 121, with only one study having over a hundred participants (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>). Participants were people with schizophrenia or other schizophrenia‐like illnesses, that is schizoaffective and schizophreniform disorder. Participants were typically diagnosed using Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM‐IV) Axis I diagnosis. The majority of studies included people aged between 18 and 60 years. Four of the included studies did not specify an age range; however, all studies reported a mean age. All studies reported including males and females, from the demographics presented in six of the seven studies there were 290 males to 91 females. <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a> did not describe the number of female and male participants in whole numbers. <a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a> only described the number of male and female participants who did not withdraw from the study. </p> </section> <section id="CD012844-sec-0098"> <h5 class="title">5. Interventions</h5> <p>We included interventions that were called 'video games' or 'computer games'; for full inclusion criteria see <a href="#CD012844-sec-0019">Types of interventions</a>. Four studies referred to 'computer games', whilst three referred to 'video games' (<a href="./references#CD012844-bbs2-0028" title="KantrowitzJT , SharifZ , MedaliaA , KeefeRS , HarveyP , BruderG , et al. A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry2016;77(6):799-806. [CSZG: 33685]NCT01173874. Clinical and biomarker assessment of efficacy of cognitive remediation in patients with schizophrenia stabilized on lurasidone. ClinicalTrials.gov/show/NCT01173874 (first received August 2, 2010). [CSZG: 21088]">Kantrowitz 2016</a>; <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). </p> <section id="CD012844-sec-0099"> <h6 class="title">5.1 Video games</h6> <section id="CD012844-sec-0100"> <p><b>5.1.1 Non‐exergames</b></p> <p>The descriptions of the non‐exergames were inexact. <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a> used commercially available arcade and puzzle video games, whilst <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a> and <a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a> used 16 different graphics‐based, commercially available games (e.g. visuospatial puzzle games, clue‐gathering mystery games). <a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a> employed 10 computerised games that were stated to be "enjoyable". We identified no studies for inclusion that compared non‐exergames as the intervention against a control. </p> </section> <section id="CD012844-sec-0101"> <p><b>5.1.2 Exergames</b></p> <p>We included two studies that employed exergames. <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a> compared exergames versus standard care, whilst <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a> compared exergames with non‐exergames. Both studies used Xbox 360 Kinect (<a href="https://en.wikipedia.org/wiki/Kinect#Kinect_for_Xbox_360_(2010)" target="_blank">en.wikipedia.org/wiki/Kinect#Kinect_for_Xbox_360_(2010)</a>) (<a href="#CD012844-fig-0002">Figure 2</a>) to track and encourage participant movements. </p> <div class="figure" id="CD012844-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Xbox 360 Kinect." data-id="CD012844-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-02.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Xbox 360 Kinect.</p> </div> </div> </div> </section> </section> <section id="CD012844-sec-0102"> <h6 class="title">5.2 Cognitive remediation</h6> <p>Five studies used cognitive remediation as an intervention. Three studies used the Brain Fitness Program developed by Posit Science (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>): "The Brain Fitness Program focuses on the auditory system of the brain. It speeds up and sharpens the ability to take in speech, so that the brain can hear and remember more details" (<a href="http://crsps.com.au/brainfitnessfactsheet.pdf" target="_blank">Brain Fitness Program</a>). <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a> used COGPACK v8.91 (<a href="./references#CD012844-bbs2-0102" title="Marker Software. COGPACK v8.91. -2015.">Marker Software 2015</a>), which "offers exercises to target visual‐motor functioning, comprehension, attention, memory, language use, and skills training" (<a href="https://psyberguide.org/apps/cogpack/" target="_blank">psyberguide.org/apps/cogpack/</a>). <a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a> used a cognitive remediation programme, but provided no further detail. </p> </section> </section> <section id="CD012844-sec-0103"> <h5 class="title">6. Outcomes</h5> <p>An array of outcome measures were implemented to clinically assess participant response, yet we were unable to report on a select number of outcome measures due to poor reporting of data. We have presented details of the outcome measures we were able to include below. </p> <section id="CD012844-sec-0104"> <h6 class="title">6.1 Functioning</h6> <section id="CD012844-sec-0105"> <p><b>6.1.1 General</b></p> <p> <ul id="CD012844-list-0005"> <li> <p>Independent Living Skills Survey ‐ ILSS (<a href="http://www.riabilitazionepsicosociale.it/wordpress/wp-content/uploads/2016/04/The-Independent-Living-Skills-Survey.pdf" target="_blank">ILSS 2000</a>) </p> </li> </ul> </p> <p>The ILSS is a questionnaire designed to assess the functioning of severely mentally ill individuals. It rates how often the individual performs the tasks needed to live a satisfying, independent life in the community. These tasks typically include taking care of one's personal appearance, money, possessions, residence, and health; finding and keeping a job; and interacting with others. The questionnaire asks how often the individual performed each of these tasks during the past 30 days by choosing the options of: always, usually, often, sometimes, never or no opportunity. </p> <p> <ul id="CD012844-list-0006"> <li> <p>Medication Adherence Rating Scale ‐ MARS (<a href="./references#CD012844-bbs2-0133" title="ZemmourK , TinlandA , BoucekineM , GirardV , LoubiereS , ResseguierN , et al. Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: results from the French Housing First experience. Scientific Reports2016;6:31598. [PMID: 27534796]">Zemmour 2016</a>) </p> </li> </ul> </p> <p>The MARS is a 10‐item self‐reported questionnaire that incorporates the Medical Adherence Questionnaire and the Drug Attitude Inventory, both which are validated for individuals with psychosis. A higher score in the questionnaire infers a better adherence to medication. </p> <p> <ul id="CD012844-list-0007"> <li> <p>Strauss Carpenter Outcome Scale (<a href="./references#CD012844-bbs2-0109" title="NiemanDH , VelthorstE , BeckerHE , deHaanL , DingemansPM , LinszenDH , et al. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis. Acta Psychiatrica Scandinavica2013;127(1):53-61. [PMID: 22775300]">Nieman 2013</a>) </p> </li> </ul> </p> <p>This is a 21‐item scale referring to aspects such as: quantity and quality of useful work, social class, social and heterosexual relationships, medical family history, violent or suicidal tendencies, flat effect, delusions, hallucinations, hypomania or mania in the previous year. Each item is rated using a 5‐point severity scale, with higher scores indicating a more positive prognosis. </p> <p> <ul id="CD012844-list-0008"> <li> <p>University of California San Diego Performance Based Skills Assessment ‐ UPSA (<a href="./references#CD012844-bbs2-0118" title="PattersonTL , GoldmanS , McKibbinCL , HughsT , JesteDV . UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin2001;27(2):235-45. [PMID: 11354591]">Patterson 2001</a>) </p> </li> </ul> </p> <p>The UPSA measures the capability to implement everyday functioning, assessing skills in five areas: communication, finance, household tasks, transportation, and free‐time activity planning. Raw scores from each of these subscales are transformed into a 0‐to‐10 scale, and are then doubled, and scores from all subscales are added to give a total summary score from 0 to 100. A higher score indicates a more capable individual. </p> </section> <section id="CD012844-sec-0106"> <p><b>6.1.2 Cognitive</b></p> <p> <ul id="CD012844-list-0009"> <li> <p>Cognitive Assessment Interview ‐ CAI (<a href="./references#CD012844-bbs2-0129" title="VenturaJ , ReiseSP , KeefeRS , HurfordIM , WoodRC , BilderRM . The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition. Schizophrenia Bulletin2013;39(3):583-91. [PMID: 22328641]">Ventura 2013</a>) </p> </li> </ul> </p> <p>The CAI was produced from two parent interview assessments: the CGI‐CogS and the SCoRS. It uses 10 items to assess the majority of the MATRICS cognitive domains (6 of 7) and is rated using a 7‐point severity scale, with higher scores indicating worse cognitive functioning. </p> <p> <ul id="CD012844-list-0010"> <li> <p>MATRICS Consensus Cognitive Battery ‐ MCCB (<a href="./references#CD012844-bbs2-0104" title="McCleeryA , VenturaJ , KernRS , SubotnikKL , Gretchen-DoorlyD , GreenMF , et al. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophrenia Research2014;157(1-3):33-9. [PMID: 24888526]">McCleery 2014</a>) </p> </li> </ul> </p> <p>The MCCB is compiled of 10 tests that assess seven areas of cognition: processing speed, attention, working memory, verbal learning, reasoning and problem solving, visual learning, and social cognition. The MCCB also gives an overall composite score across all these domains. A higher score indicates better cognitive functioning. Four studies reported outcome data from this scale. Two further studies were conducted before the full MCCB was available (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>), and instead used measures consistent with the MCCB test that had been published and recommended by MATRICS before the full release of the test. </p> </section> <section id="CD012844-sec-0107"> <p><b>6.1.3 Social</b></p> <p> <ul id="CD012844-list-0011"> <li> <p>Global Functioning: Role and Social Scales (<a href="./references#CD012844-bbs2-0068" title="CornblattBA , AutherAM , NiendamT , SmithCW , ZinbergJ , et al. Preliminary Findings for Two New Measures of Social and Role Functioning in the Prodromal Phase of Schizophrenia. Schizophrenia Bulletin2007;33(3):688-702.">Cornblatt 2007</a>) </p> </li> </ul> </p> <p>The Global Functioning Role and Social scales are clinician‐rated metrics that take into account age and stage of illness. The role scale assesses performance in school, work, or as a homemaker, depending on age. The social scale assesses quantity and quality of peer relationships, level of peer conflict, ageappropriate intimate relationships, and involvement with family members. One Study re[prted outcome data from these scales. </p> <p> <ul id="CD012844-list-0012"> <li> <p>Social and Occupational Functioning Assessment Scale ‐ SOFAS (<a href="./references#CD012844-bbs2-0120" title="RybarczykB . Social and Occupational Functioning Assessment Scale (SOFAS). In: KreutzerJS , DeLucaJ , CaplanB , editors(s). Encyclopedia of Clinical Neuropsychology. New York, NY: Springer New York, 2011:2313.">Rybarczyk 2011</a>) </p> </li> </ul> </p> <p>The SOFAS focuses on the social and occupational functioning of the patient independent from the severity of the patient's illness. The score ranges from 0 to 100, with a lower score indicating more diminished level of functioning. One study reported outcome data from this scale. </p> <p> <ul id="CD012844-list-0013"> <li> <p>Specific Levels of Functioning Scale ‐ SLOF (<a href="./references#CD012844-bbs2-0108" title="MucciA , RucciP , RoccaP , BucciP , GibertoniD , MerlottiE , et al. The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community. Schizophrenia Research2014;159(1):144-50. [PMID: 25182540]">Mucci 2014</a>) </p> </li> </ul> </p> <p>The SLOF consists of 43 items and does not focus on cognitive functioning or symptoms, but rather a person's skills, assets, and abilities. The scale measures physical functioning, personal care, social relationships, social acceptability, recreational activities, and work skills and is rated with a 5‐point Likert scale, with a higher score indicating higher function. One study reported outcome data from this scale. </p> </section> </section> <section id="CD012844-sec-0108"> <h6 class="title">6.2 Mental state</h6> <p> <ul id="CD012844-list-0014"> <li> <p>Positive and Negative Syndrome Scale ‐ PANSS (<a href="./references#CD012844-bbs2-0093" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda (NY): Multi-Health Systems, 1986.">Kay 1986</a>) </p> </li> </ul> </p> <p>The PANSS consists of 30 items and is rated using a seven‐point severity scale, from absent to severe. It measures positive symptoms, negative symptoms, and an overall total score of general psychopathology, with a higher score indicating more severe symptoms. Four studies reported an average total score from this scale, whilst two studies collected separate data for both positive and negative symptoms (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>; <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a>). </p> </section> <section id="CD012844-sec-0109"> <h6 class="title">6.3 Physical fitness</h6> <p> <ul id="CD012844-list-0015"> <li> <p>Aerobic fitness ‐ AF (<a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>) </p> </li> </ul> </p> <p>AF is a measure of various sustained exercises, such as jogging, rowing, swimming, or cycling, that stimulate and strengthen the heart and lungs, thereby improving the body's utilisation of oxygen. AF is measured as peak oxygen uptake (VO<sub>2</sub> peak) mL/kg/min. </p> <p> <ul id="CD012844-list-0016"> <li> <p>Brain‐derived neurotrophic factor ‐ BDNF (<a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>) </p> </li> </ul> </p> <p>BDNF is the most abundant of the growth factor family and has a wide repertoire of neurotrophic and neuroprotective properties in the central nervous system. Amongst individuals with schizophrenia, reports point to lower serum BDNF being linked to poor memory and smaller hippocampal volumes. </p> <p> <ul id="CD012844-list-0017"> <li> <p>Short Physical Performance Battery ‐ SPPB (<a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>) </p> </li> </ul> </p> <p>The SPBB is a valid and reliable test for quantifying function and mobility and is useful in following change in walking speed over time. The test can also be useful for identifying individuals in a 'preclinical' stage of disability who may be ideal to target with disability‐delaying interventions. </p> </section> <section id="CD012844-sec-0110"> <h6 class="title">6.4 Global state</h6> <p> <ul id="CD012844-list-0018"> <li> <p>Clinical Global Impression Scale ‐ CGI (<a href="https://en.wikipedia.org/wiki/Clinical_Global_Impression" target="_blank">Guy 2000</a>) </p> </li> </ul> </p> <p>The CGI measures symptom severity, treatment response, and the efficacy of treatments in treatment studies of individuals with mental disorders. </p> </section> <section id="CD012844-sec-0111"> <h6 class="title">6.5 Quality of life</h6> <p> <ul id="CD012844-list-0019"> <li> <p>EUROHIS‐QOL (<a href="./references#CD012844-bbs2-0119" title="Power, M. Development of a common instrument for quality of life. In: NosikovA , GudexC , editors(s). EUROHIS: Developing Common Instruments for Health Surveys. Amsterdam, The Netherlands: IOS Press, 2003:145-164.">Power 2003</a>) </p> </li> </ul> </p> <p>Part of the WHO EUROHIS project to develop common survey instruments that could enhance the international comparability of national health data, the EUROHIS‐QOL scale is a shortened version of the World Health Organization Quality of Life Instrument‐Abbreviated Version (WHOQOL‐BREF). It is a survey using an eight‐item index to measure quality of life. One study reported data from this scale. </p> <p> <ul id="CD012844-list-0020"> <li> <p>Perceived Competence Scale ‐ PCS (http:// feelings of being able to stick with a treatment regimen and being able to master the material in a course.) </p> </li> </ul> </p> <p>The PCS is a short, 4‐item questionnaire that evaluates the feelings of being able to stick with a treatment regimen and master the material in a course. </p> <p> <ul id="CD012844-list-0021"> <li> <p>Quality of Life Scale ‐ QLS (<a href="./references#CD012844-bbs2-0084" title="HeinrichsDW , HanlonTE , Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin1984;10(3):388-98. [PMID: 6474101]">Heinrichs 1984</a>) </p> </li> </ul> </p> <p>The QLS consists of 21 items where participants provide information on symptoms and functioning through a semi‐structured interview. It is rated using a 7‐point scale, with 5 to 6 being relatively good functioning and 0 to 1 being relatively bad. One study reported outcome data from this scale. One study used an alternate version of this scale, the European Health Interview Survey (EUROHIS‐QOL), which is based on the same scale (<a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a>). </p> <p> <ul id="CD012844-list-0022"> <li> <p>Intrinsic Motivation Inventory‐Schizophrenia Research Intrinsic Motivation Inventory ‐ IMI‐SR (<a href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0102-79722015000300434" target="_blank">Monteiro 2015</a>) </p> </li> </ul> </p> <p>The IMI is a multidimensional measurement grounded on self‐determination theory that is used in assessing the subjective experiences of participants when developing an activity. </p> <p> <ul id="CD012844-list-0023"> <li> <p>Revised Self‐Efficacy Scale (<a href="https://www.cambridge.org/core/journals/journal-of-the-international-neuropsychological-society/article/neurocognitive-and-selfefficacy-benefits-of-cognitive-remediation-in-schizophrenia-a-randomized-controlled-trial/720511AED0F222BB137B8E838FF56194" target="_blank">Cardenas 2013</a>) </p> </li> </ul> </p> <p>This is a self‐report scale focusing on a participant’s confidence in their ability to complete everyday living and social behaviours (e.g. 'attend classes' and 'make friends') (<a href="https://www.cambridge.org/core/journals/journal-of-the-international-neuropsychological-society/article/neurocognitive-and-selfefficacy-benefits-of-cognitive-remediation-in-schizophrenia-a-randomized-controlled-trial/720511AED0F222BB137B8E838FF56194" target="_blank">Cardenas 2013</a>). Items are rated on a 5‐point scale ranging from 1 (not at all confident) to 5 (extremely confident). Higher scores represent higher levels of self‐efficacy. </p> <p> <ul id="CD012844-list-0024"> <li> <p>Rosenberg Self‐Esteem Scale (<a href="https://en.wikipedia.org/wiki/Rosenberg_self-esteem_scale" target="_blank">The Betsi Cadwaladr University Health Board 2017</a>) </p> </li> </ul> </p> <p>This is a self‐esteem (<a href="https://en.wikipedia.org/wiki/Self-esteem" target="_blank">en.wikipedia.org/wiki/Self-esteem</a>) measure widely used in social science research. Individuals are rated on a scale of 0 to 30, where a score of less than 15 may indicate a problematic low self‐esteem. </p> </section> </section> <section id="CD012844-sec-0112"> <h5 class="title">7. Missing outcomes</h5> <p>Data were reported on the majority of primary outcomes. No data were reported for adverse effects, so we used study attrition rates as a poor‐quality metric for adverse effects. No economic or service use outcomes were reported. </p> </section> </section> <section id="CD012844-sec-0113"> <h4 class="title">Excluded studies</h4> <p>We excluded 41 studies from the review. We excluded four studies because of lack of randomisation (<a href="./references#CD012844-bbs2-0023" title="HanDH , RenshawPF , SimME , KimJI , ArenellaLS , LyooIK . The effect of internet video game play on clinical and extrapyramidal symptoms in patients with schizophrenia. Schizophrenia Research2008;103(1-3):338-40. [PMID: 18304782]">Han 2008</a>; <a href="./references#CD012844-bbs2-0024" title="HeggelundJ , NilsbergGE , HoffJ , MorkenG , HelgerudJ . Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial. Nordic Journal of Psychiatry2011;65(4):269-75. [PMID: 21332297]NCT00286299. Aerobic endurance training and effect on symptoms of schizophrenia. https://clinicaltrials.gov/ct2/show/NCT00286299 (first received February 3, 2006). ">Heggelund 2011</a>; <a href="./references#CD012844-bbs2-0040" title="SaleemMM , HarteMK , MarshallKM . Positive effects of a novel cognitive remediation computer game (X-Cog) in first episode psychosis: a pilot study. Psychosis (in press). ">Saleem 2013</a>; <a href="./references#CD012844-bbs2-0045" title="WuYJ , TsaiYF , WuWC , WangJS . The effects of a biosensing game on the physical health-related fitness of chronic schizophrenic patients. Journal of Nursing2016;63(1):49-58. [CSZG: 33453]">Wu 2016</a>). We excluded nine studies because participants did not have schizophrenia or not a large enough sample of participants had schizophrenia, or data for those with schizophrenia were not reported separately. We excluded 18 studies because the intervention was not a 'video game' or 'computer game'. We excluded one study because the intervention was a virtual reality game (<a href="./references#CD012844-bbs2-0032" title="Lopez-MartinO , Segura FragosoA , Rodriguez HernandezM , Dimbwadyo TerrerI , Polonio-LopezB . Effectiveness of a programme based on a virtual reality game for cognitive enhancement in schizophrenia. Gaceta Sanitaria/S.E.S.P.A.S2016;30:133-6. [CSZG: 33705]">Lopez 2016</a>). Regrettably, we excluded six studies because no useable outcome data were reported. In <a href="./references#CD012844-bbs2-0009" title="BarnettO . Nonprofessionals in the rehabilitation of mentally disordered sex offenders. Community Mental Health Journal1978;14(2):110-5. [PMID: 699527]">Barnett 1978</a>, both the participants were not diagnosed with schizophrenia and the intervention was not a video game. </p> <section id="CD012844-sec-0114"> <h5 class="title">Studies awaiting classification</h5> <p>There are currently no studies awaiting classification.</p> </section> <section id="CD012844-sec-0115"> <h5 class="title">Ongoing studies</h5> <p>We have extracted some data from seven ongoing studies that were due to be completed by December 2019. However, three of these 11 studies (listed) did not specify an estimated completion date (<a href="./references#CD012844-bbs2-0049" title="EnghJA , AndersenE , HolmenTL , MartinsenEW , MordalJ , MorkenG , et al. Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. Trials2015;16(1):557. NCT02205684. Effects of aerobic high intensity training on symptoms, cognition, cortical structure, substance use and metabolic indices in patients with schizophrenia spectrum disorder. Clinicaltrials.gov/show/NCT02205684 (first received July 31, 2014). ">Engh 2015</a>; <a href="./references#CD012844-bbs2-0051" title="NCT03522220. Augmentation of neuronal network plasticity in schizophrenia. clinicaltrials.gov/ct2/show/NCT03522220 (first received May 11, 2018). ">Kuehn 2018</a>; <a href="./references#CD012844-bbs2-0054" title="NCT03133143. Video games among people with schizophrenia. clinicaltrials.gov/ct2/show/NCT03133143 (first received April 28, 2017). ">Valimaki 2017</a>). One of these (<a href="./references#CD012844-bbs2-0054" title="NCT03133143. Video games among people with schizophrenia. clinicaltrials.gov/ct2/show/NCT03133143 (first received April 28, 2017). ">Valimaki 2017</a>) has had its protocol recently accepted in the BMC, the study is still ongoing due to political and COVID‐19 related restrictions. </p> </section> </section> </section> <section id="CD012844-sec-0116"> <h3 class="title">Risk of bias in included studies</h3> <p>Our overall response to the risk of bias assessment in the included studies is also shown in <a href="#CD012844-fig-0003">Figure 3</a> and <a href="#CD012844-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD012844-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012844-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012844-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012844-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD012844-sec-0117"> <h4 class="title">Allocation</h4> <p>All included studies reported randomisation. The method of randomisation used in the studies was generally well reported, with only two trials not fully disclosing their methods for randomisation (<a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). No study disclosed the method of allocation concealment, therefore we have rated all included studies as at unclear risk for allocation concealment. </p> </section> <section id="CD012844-sec-0118"> <h4 class="title">Blinding</h4> <p>Five studies described single‐blinding (of assessors) without blinding of participants; one of these studies had conflicting documentation in different reports regarding blinding (<a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>), but we assessed this trial as being single‐blinded. One study reported double‐blinding (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>), however given the nature of the intervention and control, it is not clear how this was achieved. One study did not document any blinding (<a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). </p> <p>The necessary lack of full blinding in most of the studies led to an unclear risk of bias in this area ‐ most studies included assessor blinding, with mixed success (where effectiveness of blinding was reported), but not participant blinding. Where it was stated that participants were blinded, it was not clear how this was achieved given the nature of the intervention and control. We have therefore assessed all included trials as at unclear risk for blinding. </p> </section> <section id="CD012844-sec-0119"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed five studies that used an intention‐to‐treat (ITT) analysis as at low risk of attrition bias (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>; <a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>; <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). We rated two studies that did not specify how they accounted for attrition within their final data as at unclear risk of attrition bias (<a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>; <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a>). </p> </section> <section id="CD012844-sec-0120"> <h4 class="title">Selective reporting</h4> <p>Although we have not been able to obtain any protocols for the included studies, four of the seven included trials reported all useable outcome data and were therefore rated as at low risk of reporting bias (<a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>; <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>). We assessed two studies as at high risk of reporting bias: <a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a> stated "Three quarters (77%) of CR [cognitive remediation] completers showed a reliable improvement" with no mention of the proportion in the control group using only video games, whilst <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a> reported PANSS and quality of life at baseline and not postintervention. </p> </section> <section id="CD012844-sec-0121"> <h4 class="title">Other potential sources of bias</h4> <p>We noted another potential source of bias for three studies that involved auditory‐focused cognitive remediation (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>). All of these studies, whose authors overlap, used the same software, and involved at least one researcher with a financial connection to the company responsible for this software. The company in question provided the software free of charge in two of these studies (<a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a>; <a href="./references#CD012844-bbs2-0003" title="AdcockRA , DaleC , FisherM , AldebotS , GenevskyA , SimpsonGV , et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophrenia Bulletin2009;35(6):1132-41. [CSZG: 19637] [PMID: 19745022]DaleCL , BrownEG , FisherM , HermanAB , DowlingAF , HinkleyLB , et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophrenia Bulletin2016;42(1):220-8. [CSZG: 33533]DaleCL , FindlayAM , AdcockRA , VertinskiM , FisherM , GenevskyA , et al. Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. International Journal of Psychophysiology2010;75(2):183-93. [CSZG: 29427]FisherM , GarrettC , AlexanderP , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: a final report on the effects 6-12 months later. Schizophrenia Research2012;136:S339. [CSZG: 29442]FisherM , HollandC , MerzenichMM , VinogradovS . Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry2009;166(7):805-11. [CSZG: 18685] [PMID: 19448187]FisherM , HollandC , SubramaniamK , VinogradovS . Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin2010;36(4):869-79. [CSZG: 20758]FisherM , MellonSH , WolkowitzO , VinogradovS . Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition2016;3:1-7. [CSZG: 33643]GenevskyA , FisherM , GarrettCT , CookC , VinogradovS . Increased serum BDNF induced by cognitive training in schizophrenia is negatively associated with baseline SAA. Schizophrenia Research2010;117(2-3):368. [CSZG: 20594]GenevskyA , GarrettCT , AlexanderPP , VinogradovS . Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues in Clinical Neuroscience2010;12(3):416-21. [CSZG: 21970] [PMID: 20954435]HinkleyLB , VinogradovS , GuggisbergAG , FisherM , FindlayAM , NagarajanSS . Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment. Biological Psychiatry2011;70(12):1134-42. [CSZG: 29459]HollandC , VinogradovS , MerzenichM . Neuroplasticity-based cognitive training in schizophrenia. Schizophrenia Bulletin2007;33(2):524. [CSZG: 15170]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research2013;213(2):99-107. [CSZG: 28529]HookerCI , BruceL , FisherM , VeroskySC , MiyakawaA , VinogradovS . Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research2012;139(1-3):53-9. [CSZG: 24353]I'Lee HookerC , BruceL , FisherM , VeroskySC , MiyakawaA , D'EspositoM , et al. The influence of combined cognitive and social-cognitive training on amygdala response during face emotion processing in schizophrenia. Schizophrenia Bulletin2011;37:140. [CSZG: 22779]NCT00312962. Neuroscience-guided remediation of cognitive deficits in schizophrenia. clinicaltrials.gov/ct2/show/NCT00312962 (first received April 11, 2006). [CSZG: 14649]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]SubramaniamK , LuksT , AldebotS , HearstA , ThangavelA , FisherM , et al. Neuroplasticity-based cognitive training improves reality monitoring in schizophrenia patients: behavioral and fMRI assessments. Schizophrenia Research2010;117(2-3):471. [CSZG: 21831]SubramaniamK , LuksTL , AldebotS , HearstA , ThangavelA , SimpsonGV , et al. Cortical plasticity in schizophrenia patients after cognitive training: behavioral and fMRI assessments of working memory performance. Schizophrenia Bulletin2011;37:230. [CSZG: 22818]SubramaniamK , LuksTL , FisherM , SimpsonGV , NagarajanS , VinogradovS . Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron2012;73(4):842-53. [CSZG: 29677]SubramaniamK , LuksTL , GarrettC , ChungC , FisherM , NagarajanS , et al. Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. NeuroImage2014;99:281-92. [CSZG: 29027]SubramaniamK , WoolleyJD , LuksTL , GarrettC , NagarajanS , VinogradovS . Cortical plasticity in schizophrenia patients after computerized cognitive training: behavioral and fMRI assessments of working memory performance. Biological Psychiatry2011;9(Suppl 1):239. [CSZG: 22936]VinogradovS , AlexanderP , QuittnerZ , FisherM , JarasitisG , FarielloD . A double-blind controlled trial of computerized cognitive training in a community mental health supported employment program. Schizophrenia Bulletin2013;39:S310. [CSZG: 28118]VinogradovS , FisherM , HollandC , ShellyW , WolkowitzO , MellonSH . Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?Biological Psychiatry2009;66(6):549-53. [CSZG: 18809] [MEDLINE: 19368899]VinogradovS , FisherM , WarmH , HollandC , KirshnerMA , PollockBG . The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry2009;166(9):1055-62. [CSZG: 18775] [MEDLINE: 19570929]VinogradovS , SubramaniamK , BiagiantiB , HookerC , FisherM . Combining cognitive and social cognitive training for individuals with schizophrenia. Schizophrenia Research2014;153:S27. [CSZG: 29704]VinogradovS , SubramaniamK , HermanA , WoolleyJ , LuksT , FisherM , et al. Neuroscience-informed cognitive training in schizophrenia normalizes brain-behavior associations in auditory and verbal working memory processes: evidence from MEG and fMRI. In: 50th Annual Meeting of the American College of Neuropsychopharmacology; 2011 Dec 4-8; Waikoloa, Hawaii. ACNP, 2011. [CSZG: 23673]VinogradovS . Self vs. Other in schizophrenia: what behavioral, neural, and cognitive training experiments tell us about future treatment directions. Neuropsychopharmacology2010;35:S77. [CSZG: 24461]">Aud CR: Vinogradov 2014</a>). Whilst these conflicts of interest were properly and openly declared, we have still noted them as a potential source of bias. </p> <p><a href="./references#CD012844-bbs2-0001" title="BiagiantiB , RoachBJ , FisherM , LoewyR , FordJM , VinogradovS , et al. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatric Electrophysiology2017;3:2. [CSZG: 35959] [DOI: 10.1186/s40810-017-0024-9] [PMID: 28845238]FisherM , LoewyR , CarterC , LeeA , RaglandJD , NiendamT , et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin2015;41(1):250-8. [CSZG: 29309]LoewyR , FisherM , CarterCS , NiendamTA , Daniel RaglandJ , MathalonD , et al. Improved cognition and positive symptoms with targeted auditory processing training in recent-onset schizophrenia: 6-month follow-up. Schizophrenia Bulletin2015;41:S87. [CSZG: 29533]NCT00694889. Randomized clinical trial of intensive computer-based cognitive remediation in recent-onset schizophrenia. clinicaltrials.gov/ct2/show/NCT00694889 (first received June 11, 2008). [CSZG: 16248]PanizzuttiR , HamiltonSP , VinogradovS . Genetic correlate of cognitive training response in schizophrenia. Neuropharmacology2013;64:264-7. [PMID: 22992330]RamsayI , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Targeted cognitive training is neuroprotective against thalamic volume loss in early schizophrenia. Schizophrenia Bulletin2017;43:S49. [CSZG: 36027]RamsayI , RoachB , FryerS , FisherM , LoewyR , VinogradovS , et al. Increased thalamo-temporal connectivity following targeted cognitive training in schizophrenia. Biological Psychiatry2018;83(9 Suppl 1):S229-30. [CSZG: 38340]RamsayIS , FryerS , BoosA , RoachBJ , FisherM , LoewyR , et al. Response to targeted cognitive training correlates with change in thalamic volume in a randomized trial for early schizophrenia. Neuropsychopharmacology2017;43(3):590-7. [CSZG: 37917] [DOI: 10.1038/npp.2017.213]VinogradovS , FisherM , LoewyR , NiendamTA , RaglandD , CarterC . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Schizophrenia Bulletin2013;39:S357. [CSZG: 28117]VinogradovS , LoewyR , FisherM , LeeA , NiendamT , RaglandJD , et al. Neuroplasticity-based cognitive training in ultra-high risk adolescents and recent onset patients with schizophrenia. Schizophrenia Research2012;136:S30. [CSZG: 29703]VinogradovS . Neuroscience-informed cognitive training in recent onset schizophrenia using laptop computer. Biological Psychiatry2013;73(9 Suppl):134S. [CSZG: 28107]">Aud CR: Fisher 2014</a> used 'alternative forms' of tests from the MCCB and did not reassure the reader as to the validity of these tests, so we did not include these in the analysis. </p> </section> </section> <section id="CD012844-sec-0122"> <h3 class="title" id="CD012844-sec-0122">Effects of interventions</h3> <p>See: <a href="./full#CD012844-tbl-0001"><b>Summary of findings 1</b> VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION (plus standard care) for people with schizophrenia</a>; <a href="./full#CD012844-tbl-0002"><b>Summary of findings 2</b> VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia</a>; <a href="./full#CD012844-tbl-0003"><b>Summary of findings 3</b> VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia</a> </p> <section id="CD012844-sec-0123"> <h4 class="title">1. COMPARISON 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term) </h4> <section id="CD012844-sec-0124"> <h5 class="title">1.1 Functioning: 1a. General ‐ average endpoint score (various scales, high = good) ‐ by end of treatment </h5> <p>Three studies measured general functioning using four different general functioning scales (<a href="./references#CD012844-fig-0005" title="">Analysis 1.1</a>). </p> <section id="CD012844-sec-0125"> <h6 class="title">1.1.1 ILSS</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (mean difference (MD) 0.03, 95% confidence interval (CI) −0.04 to 0.09; participants = 43; studies = 1). </p> </section> <section id="CD012844-sec-0126"> <h6 class="title">1.1.2 MARS</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD −0.09, 95% CI −0.42 to 0.24; participants = 78; studies = 1). </p> </section> <section id="CD012844-sec-0127"> <h6 class="title">1.1.3 Strauss Carpenter Outcome Scale</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD 0.42, CI −0.62 to 1.46; participants = 86; studies = 1, <i>very low‐</i> quality <i>evidence</i>). </p> </section> <section id="CD012844-sec-0128"> <h6 class="title">1.1.4 UPSA ‐ total</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD 1.72, 95% CI −29.92 to 33.36; participants = 53; studies = 1). </p> </section> <section id="CD012844-sec-0129"> <h6 class="title">1.1.5 UPSA ‐ communication</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD −0.95, 95% CI −3.33 to 1.43; participants = 78; studies = 1). </p> </section> <section id="CD012844-sec-0130"> <h6 class="title">1.1.6 UPSA ‐ comprehension/planning</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD −1.90, 95% CI −3.97 to 0.17; participants = 78; studies = 1). </p> </section> <section id="CD012844-sec-0131"> <h6 class="title">1.1.7 UPSA ‐ financial management</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD 0.35, 95% CI −1.71 to 2.41; participants = 78; studies = 1). </p> </section> <section id="CD012844-sec-0132"> <h6 class="title">1.1.8 UPSA ‐ transportation (high = good)</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD −0.88, 95% CI −3.05 to 1.29; participants = 78; studies = 1). </p> </section> </section> <section id="CD012844-sec-0133"> <h5 class="title">1.2 Functioning: 1b. General ‐ average endpoint score (ILSS, high = good) ‐ 3‐month follow‐up </h5> <p>One study reported average ILSS endpoint scores at three‐month follow‐up. There was no clear difference between video games and cognitive remediation for this outcome (MD 0.04, 95% CI −0.03 to 0.12; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0006" title="">Analysis 1.2</a>). </p> </section> <section id="CD012844-sec-0134"> <h5 class="title">1.3 Functioning: 2a. Specific ‐ cognitive ‐ improved (MCCB, at least one domain) ‐ by end of treatment </h5> <p>In one small study, a greater number of participants in the cognitive remediation group demonstrated improvement in at least one domain of the MCCB (risk ratio (RR) 0.58, 95% CI 0.34 to 0.99; participants = 42; studies = 1, <i>low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0007" title="">Analysis 1.3</a>). </p> </section> <section id="CD012844-sec-0135"> <h5 class="title">1.4 Functioning: 2b. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite score (high = good) ‐ by end of treatment </h5> <p>Three studies reported composite scores on the MCCB. There was a clear difference in scores by end of treatment favouring the cognitive remediation group (MD −3.60, 95% CI −6.43 to −0.76; participants = 174; studies = 3; I² = 44%) (<a href="./references#CD012844-fig-0008" title="">Analysis 1.4</a>). </p> </section> <section id="CD012844-sec-0136"> <h5 class="title">1.5 Functioning: 2c. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite score) ‐ 3‐month follow‐up </h5> <p>One study reported on cognitive functioning at three‐month follow‐up. There was no clear difference in average endpoint MCCB‐composite scores between video game and cognitive remediation groups (MD −2.69, 95% CI −9.52 to 4.14; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0009" title="">Analysis 1.5</a>). </p> </section> <section id="CD012844-sec-0137"> <h5 class="title">1.6 Functioning: 2d. Specific ‐ cognitive ‐ average endpoint score (MATRICS ‐ Z score, high = good) ‐ by end of treatment </h5> <p>For Z scores on the MATRICS recommended measures that were available before the release of the full MCCB, there appeared to be no clear difference between video games and cognitive remediation, but data were skewed and have been reported in tabular form (participants = 173; studies = 2) (<a href="./references#CD012844-fig-0010" title="">Analysis 1.6</a>). </p> </section> <section id="CD012844-sec-0138"> <h5 class="title">1.7 Functioning: 2e. Specific ‐ cognitive ‐ average endpoint score (CAI, high = poor) ‐ by end of treatment </h5> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD 0.24, 95% CI −0.25 to 0.73; participants = 53; studies = 1) (<a href="./references#CD012844-fig-0011" title="">Analysis 1.7</a>). </p> </section> <section id="CD012844-sec-0139"> <h5 class="title">1.8 Functioning: 3a. Specific ‐ social ‐ average endpoint score (Global Functioning: Role and Social Scales, high = good) ‐ by end of treatment </h5> <p>One study measured social functioning using the Role and Social Scales (<a href="./references#CD012844-fig-0012" title="">Analysis 1.8</a>). </p> <section id="CD012844-sec-0140"> <h6 class="title">1.8.1 Global functioning role</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD −0.08, 95% CI −1.15 to 0.99; participants = 86; studies = 1). </p> </section> <section id="CD012844-sec-0141"> <h6 class="title">1.8.2 Global functioning social</h6> <p>There was no clear difference between video games and cognitive remediation for this outcome (MD 0.16, 95% CI −0.43 to 0.75; participants = 86; studies = 1). </p> </section> </section> <section id="CD012844-sec-0142"> <h5 class="title">1.9 Functioning: 3b. Specific ‐ social ‐ average endpoint score (SLOF, high = good) ‐ by end of treatment </h5> <p>One study measured social functioning using the SLOF. These data were skewed to some degree, with the video games group having moderate skew and the control group not exhibiting skew. We were not sure if we should remove these data and report them in tabular form (as per <a href="#CD012844-sec-0047">Data extraction and management</a>), but in the end we left them in the analysis. There was no clear difference between video games and cognitive remediation for this outcome (MD −3.13, 95% CI −40.17 to 33.91; participants = 53; studies = 1, <i>very low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0013" title="">Analysis 1.9</a>). </p> </section> <section id="CD012844-sec-0143"> <h5 class="title">1.10 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ by end of treatment </h5> <p>Four studies reported mental state using the PANSS total. There was no clear difference between the average endpoint scores of participants in the video game groups and those of participants in the cognitive remediation groups (MD 0.20, 95% CI −3.89 to 4.28; participants = 269; studies = 4, <i>low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0014" title="">Analysis 1.10</a>). The <a href="./references#CD012844-bbs2-0002" title="KeefeRSE , VinogradovS , MedaliaA , BuckleyPF , CaroffSN , D'SouzaDC , et al. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. Journal of Clinical Psychiatry2012;73(7):1016-22. [CSZG: 24495]NCT00930150. Feasibility of providing cognitive remediation to people with schizophrenia in a clinical network. clinicaltrials.gov/ct2/show/NCT00930150 (first received June 30, 2009). [CSZG: 18473]">Aud CR: Keefe 2012</a> data were very skewed. Their means were similar to the other studies, but the standard deviation (SD) denotes considerable skew. We checked these data, and they are the only tables that clearly state that the variance is reported as a standard error, and from this we have calculated the SD. The other studies clearly state that they are reporting the SD. Again, we were unsure how best to include these data, and again have left them in the analyses as their removal made no substantial difference to the final result (MD 0.15, 95% CI −3.95 to 4.25). </p> </section> <section id="CD012844-sec-0144"> <h5 class="title">1.11 Mental state: 1b. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ 3‐month follow‐up </h5> <p>One trial reported endpoint PANSS total scores at three‐month follow‐up. There was still no clear difference between treatment groups (MD −5.58, 95% CI −15.31 to 4.15; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0015" title="">Analysis 1.11</a>). </p> </section> <section id="CD012844-sec-0145"> <h5 class="title">1.12 Mental state: 2a. Specific ‐ negative ‐ average endpoint (PANSS negative, high = poor) ‐ by end of treatment </h5> <p>Two studies reported on negative symptoms using the PANSS negative subscale. There was no clear difference between treatment groups for this outcome (MD 0.45, 95% CI −1.63 to 2.53; participants = 121; studies = 2) (<a href="./references#CD012844-fig-0016" title="">Analysis 1.12</a>). </p> </section> <section id="CD012844-sec-0146"> <h5 class="title">1.13 Mental state: 2b. Specific ‐ positive ‐ average endpoint (PANSS positive, high = poor) ‐ by end of treatment </h5> <p>Two studies reported on positive symptoms using the PANSS positive subscale. There was no clear difference between treatment groups for this outcome (MD −0.34, 95% CI −2.21 to 1.54; participants = 121; studies = 2) (<a href="./references#CD012844-fig-0017" title="">Analysis 1.13</a>). </p> </section> <section id="CD012844-sec-0147"> <h5 class="title">1.14 Global state: Average endpoint score (CGI ‐ severity, high = poor) ‐ by end of treatment </h5> <p>One study reported CGI‐severity average endpoint scores. There appeared to be no clear difference between video games and cognitive remediation, but data were very skewed and have been presented in tabular form (participants = 53; studies = 1) (<a href="./references#CD012844-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD012844-sec-0148"> <h5 class="title">1.15 Leaving the study early: Did not leave</h5> <p>Five of the seven studies provided useable attrition data (<a href="./references#CD012844-fig-0019" title="">Analysis 1.15</a>). </p> <section id="CD012844-sec-0149"> <h6 class="title">1.15.1 By end of treatment</h6> <p>Five studies reported numbers of participants who did not leave the studies before the end of treatment. There was no clear difference between groups in attrition (RR 0.96, 95% CI 0.87 to 1.06; participants = 395; studies = 5). </p> </section> <section id="CD012844-sec-0150"> <h6 class="title">1.15.2 Follow‐up (3 to 9 months)</h6> <p>One study reported the number of participants available for follow‐up three to nine months after treatment. There was also no clear difference between groups in attrition (RR 1.29, 95% CI 0.83 to 2.00; participants = 56; studies = 1). </p> </section> </section> <section id="CD012844-sec-0151"> <h5 class="title">1.16 Quality of life: 1a. Overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment </h5> <p>Quality of life data reported by one study using the QLS showed no clear difference between video games and cognitive remediation (MD 0.01, CI −0.40 to 0.42; participants = 87; studies = 1, <i>very low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0020" title="">Analysis 1.16</a>). </p> </section> <section id="CD012844-sec-0152"> <h5 class="title">1.17 Quality of life: 1b. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ by end of treatment </h5> <p>Similarly, when using the EUROHIS‐QOL score to evaluate quality of life, there was no clear difference between video games and cognitive remediation (MD −0.32, 95% CI −3.34 to 2.70; participants = 43; studies = 1) (<a href="./references#CD012844-fig-0021" title="">Analysis 1.17</a>). </p> </section> <section id="CD012844-sec-0153"> <h5 class="title">1.18 Quality of life: 1c. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ 3‐month follow‐up </h5> <p>EUROHIS‐QOL quality of life data reported by one study at three‐month follow‐up showed no clear difference between video games and cognitive remediation (MD 0.58, 95% CI −2.69 to 3.85; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0022" title="">Analysis 1.18</a>). </p> </section> <section id="CD012844-sec-0154"> <h5 class="title">1.19 Quality of life: 2a. Specific ‐ well‐being ‐ improved (IMI‐SR increase in score) ‐ by end of treatment </h5> <p>One study reported improvement in specific aspect of quality of life using increase in IMI‐SR scores; the numbers of participants showing improvement were similar between treatment groups (RR 1.50, 95% CI 0.70 to 3.20; participants = 43; studies = 1) (<a href="./references#CD012844-fig-0023" title="">Analysis 1.19</a>) . </p> </section> <section id="CD012844-sec-0155"> <h5 class="title">1.20 Quality of life: 2b. Specific ‐ well‐being ‐ average endpoint score (various scales, high = good) ‐ by end of treatment </h5> <p>Two studies used various scales measuring specific aspects of quality of life, reporting average endpoint scores at the end of treatment for intrinsic motivation (IMI‐SR), competency (PCS), self‐esteem, and self efficacy. There was no clear difference between video game and cognitive remediation groups for any of these measures (<a href="./references#CD012844-fig-0024" title="">Analysis 1.20</a>). </p> <section id="CD012844-sec-0156"> <h6 class="title">1.20.1 IMI‐SR</h6> <p>(MD 5.16, 95% CI −1.22 to 11.54; participants = 96; studies = 2).</p> </section> <section id="CD012844-sec-0157"> <h6 class="title">1.20.2 PCS</h6> <p>(MD 0.36, 95% CI −2.62 to 3.34; participants = 53; studies = 1).</p> </section> <section id="CD012844-sec-0158"> <h6 class="title">1.20.3 Rosenberg Self‐Esteem Scale</h6> <p>(MD −0.69, 95% CI −3.34 to 1.96; participants = 53; studies = 1).</p> </section> <section id="CD012844-sec-0159"> <h6 class="title">1.20.4 Revised Self‐Efficacy Scale</h6> <p>(MD 9.41, 95% CI −4.85 to 23.67; participants = 43; studies = 1).</p> </section> </section> <section id="CD012844-sec-0160"> <h5 class="title">1.21 Quality of life: 2c. Specific ‐ well‐being ‐ average endpoint score (Revised Self‐Efficacy Scale) ‐ 3‐month follow‐up </h5> <p>There was also no difference between treatment groups for self‐efficacy scores at three‐month follow‐up (MD 6.13, 95% CI −7.17 to 19.43; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0025" title="">Analysis 1.21</a>). </p> </section> </section> <section id="CD012844-sec-0161"> <h4 class="title">2. COMPARISON 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term) </h4> <section id="CD012844-sec-0162"> <h5 class="title">2.1 Functioning: 1a. Specific ‐ cognitive ‐ average change score (MCCB, increase = good) </h5> <p>Change scores on the MCCB reported by one study showed no clear difference between treatment groups (MD 2.90, 95% CI ‐1.27 to 7.07; participants = 33; studies = 1, <i>low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0026" title="">Analysis 2.1</a>). </p> </section> <section id="CD012844-sec-0163"> <h5 class="title">2.2 Physical fitness: 2a. Specific ‐ average change (BDNF, increase = good)</h5> <p>The same study measured change in BDNF, finding no clear difference between exergames and standard care for this outcome (MD ‐0.13, 95% CI −3.43 to 3.17; participants = 33; studies = 1) (<a href="./references#CD012844-fig-0027" title="">Analysis 2.2</a>). </p> </section> <section id="CD012844-sec-0164"> <h5 class="title">2.3 Physical fitness 2b. Specific ‐ average change VO<sub>2</sub> peak (AF, increase = good) </h5> <p>There was a clear difference between treatment groups favouring exergames for aerobic fitness change (MD 3.82, 95% CI 1.75 to 5.89; participants = 33; studies = 1, <i>low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0028" title="">Analysis 2.3</a>). </p> </section> <section id="CD012844-sec-0165"> <h5 class="title">2.4 Leaving the study early: Did not leave</h5> <p>There was no clear difference in attrition rates (RR 1.06, 95% CI 0.75 to 1.51; participants = 33; studies = 1, <i>low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0029" title="">Analysis 2.4</a>). </p> </section> </section> <section id="CD012844-sec-0166"> <h4 class="title">3. COMPARISON 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term) </h4> <section id="CD012844-sec-0167"> <h5 class="title">3.1 Physical fitness: 1a. Specific ‐ walking speed ‐ average time (seconds taken to walk 3 metres, low = good) </h5> <p>There was no clear difference in average walking speeds of the participants (MD −0.50, 95% CI −1.17 to 0.17; participants = 28; studies = 1, <i>very low‐</i> quality <i>evidence</i>) (<a href="./references#CD012844-fig-0030" title="">Analysis 3.1</a>). </p> </section> <section id="CD012844-sec-0168"> <h5 class="title">3.2 Physical fitness: 1b. Specific ‐ average endpoint score (SPPB, high = good)</h5> <p>Similarly, there was no clear difference between the two types of video games for physical fitness, as measured indirectly by the SPPB (MD −0.30, 95% CI −1.98 to 1.38; participants = 28; studies = 1) (<a href="./references#CD012844-fig-0031" title="">Analysis 3.2</a>). </p> </section> <section id="CD012844-sec-0169"> <h5 class="title">3.3 Behaviour: 2a. Specific ‐ average number of sessions attended (of 6 total)</h5> <p>There was no clear difference between exergames and non‐exergames in session attendance (MD −0.10, 95% CI −0.48 to 0.28; participants = 28; studies = 1) (<a href="./references#CD012844-fig-0032" title="">Analysis 3.3</a>). </p> </section> <section id="CD012844-sec-0170"> <h5 class="title">3.4 Behaviour: 2b. Specific ‐ average time (minutes) at sessions (of 180 minutes in total) </h5> <p>There was likewise no clear difference between exergames and non‐exergames in session attendance when measured in minutes of sessions attended (MD −2.20, 95% CI −17.66 to 13.26; participants = 28; studies = 1) (<a href="./references#CD012844-fig-0033" title="">Analysis 3.4</a>). </p> </section> </section> <section id="CD012844-sec-0171"> <h4 class="title">4. Sensitivity analysis</h4> <section id="CD012844-sec-0172"> <h5 class="title">4.1 Implication of randomisation</h5> <p>In the event no trial was included ‐ or excluded ‐ that <i>implied</i> randomisation. All clearly stated that they were, or were not, randomised. No sensitivity analysis was undertaken </p> </section> <section id="CD012844-sec-0173"> <h5 class="title">4.2 Assumptions for lost binary data</h5> <p>Relatively small numbers of people were lost to follow up in these studies. However, not one of the studies across any of the three comparisons provided primary binary outcomes to allow us to keep to the directions of our pre‐published protocol (see <a href="#CD012844-sec-0084">Sensitivity analysis</a>). The great majority of outcomes were continuous measures and so made our pre‐specified sensitivity analyses impossible. We do not have any impression that the modest loss to follow up in these studies would have made any substantive difference to any of the results. </p> </section> <section id="CD012844-sec-0174"> <h5 class="title">4.3 Risk of bias</h5> <p>We rated three trials (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>; <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a>; <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a>) to not be at high risk in one domain. We felt all others carried a high risk in one or more domains. The <a href="./references#CD012844-bbs2-0006" title="KimhyD , VakhrushevaJ , BartelsM , BallonJ , CastrenE , SloanR . The impact of aerobic exercise on cognitive functioning and biomarkers of cognitive change in individuals with schizophrenia. Schizophrenia Bulletin2018;44(Suppl 1):S17. [CSZG: 38235]KimhyD , VakhrushevaJ , BartelsMN , ArmstrongHF , BallonJS , KhanS , ChangRW , HansenMC , AyanruohL , ListerA , CastrénE , SmithEE , SloanRP . The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia Bulletin2015;41(4):859-869. ">Kimhy 2018</a> and <a href="./references#CD012844-bbs2-0007" title="LeutwylerH , HubbardE , CooperBA , DowlingG . Impact of a pilot videogame-based physical activity program on walking speed in adults with schizophrenia. Community Mental Health Journal2018;54(6):735-9. [CSZG: 37838]">Leutwyler 2017</a> studies reported data for Comparison 2 and 3 and were the only studies to do so – so could not be analysed separately from trials which carried some clear risk of bias. <a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>, however, was part of several outcomes in Comparison 1. Although there were no outcomes reported that we had pre‐specified as being of primary importance (see <a href="#CD012844-sec-0084">Sensitivity analysis</a>, outcome <a href="./references#CD012844-fig-0008" title="">Analysis 1.4</a> was the one in which this trial was part of a meta‐analysis and removing its two less good quality companion studies did make the overall finding more clearly favour the cognitive remediation group (MD ‐9.20 CI‐15.84 to ‐2.56 vs MD ‐3.60 CI ‐6.43 to ‐0.76), but not statistically significantly so and the finding was generally the same – favouring cognitive remediation. </p> </section> <section id="CD012844-sec-0175"> <h5 class="title">4.4 Imputed values</h5> <p>No trials used a cluster randomised technique.</p> </section> <section id="CD012844-sec-0176"> <h5 class="title">4.5 Fixed‐effect and random‐effects models</h5> <p>Again – no primary outcomes were reported by any trial. We did undertake a sensity analysis on one continuous outcome (<a href="./references#CD012844-fig-0008" title="">Analysis 1.4</a>) to investigate if using the random model made a difference and it did. The original MD ‐3.60 CI ‐6.43 to ‐0.76 using the fixed model became MD ‐3.96 CI ‐8.12 to 0.20, further illustrating the instability of these results. We feel that this should not be over‐interpreted as this is not on a pre‐specified primary outcome and is opportunistic on what data happen to be reported across a few trials. Nevertheless it does cast some shadow across any confidence in being sure that video games are indeed worse than cognitive remediation when continuous measures of functioning are the outcome. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012844-sec-0177" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012844-sec-0177"></div> <section id="CD012844-sec-0178"> <h3 class="title" id="CD012844-sec-0178">Summary of main results</h3> <section id="CD012844-sec-0179"> <h4 class="title">1. VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) for schizophrenia (all short term) </h4> <p>See <a href="./full#CD012844-tbl-0001">summary of findings Table 1</a>. </p> <p>Overall, we found little evidence of clear differences between commercial, non‐exergame video games and any of the complex cognitive remediation interventions. Only one outcome, cognitive functioning, showed a clear difference between groups. We recognise that we pre‐stated only a few outcomes to be of key importance, however few of the other outcomes showed any clear effect reaching conventional levels of statistical significance. We also recognise that several of the included studies were not designed to be anything more than exploratory. Nevertheless, such studies do still have potential, especially when in the company of all others, to reveal effects of clinical importance. </p> <section id="CD012844-sec-0180"> <h5 class="title">1.1 Functioning ‐ general ‐ average endpoint score (Strauss Carpenter Outcome Scale)</h5> <p>We felt this outcome to be of primary importance to this intervention. Only one small trial (n = 86) evaluated this outcome, and reported a continuous outcome, rather than the binary, clinically important change that we prespecified. Further undermining the value of these continuous data is that the scale used is not well‐explained in terms of clinical meaning. We rated these data to be of very low quality and identified no difference between the commercial games and the more complex and expensive cognitive interventions. </p> </section> <section id="CD012844-sec-0181"> <h5 class="title">1.2 Functioning ‐ specific ‐ cognitive ‐ improved and endpoint score (MCCB)</h5> <p>Three studies evaluated this outcome, which was used to assess cognitive functioning. Two further studies reported z score data for MATRICS‐recommended measures that pre‐date the MCCB. </p> <p>Only one study reported binary data, which was measured as improved on at least one domain. There was a clear difference between treatment groups favouring cognitive remediation. As this was the only source of binary data for this outcome, the data are presented in the 'Summary of findings' table but rated as of low quality due to the poor description of randomisation and allocation concealment provided, and the small and imprecise nature of the study. We are therefore uncertain about this estimate of effect, and the true effect of cognitive remediation on cognitive functioning may be substantially different. </p> <p>Three studies reported continuous data for the MCCB, as opposed to the binary we prespecified in our protocol. We also found these data to be heterogeneous (I² = 44%). Nevertheless, there was weak evidence in these low‐quality, continuous data of a beneficial effect of cognitive remediation over video games. </p> </section> <section id="CD012844-sec-0182"> <h5 class="title">1.3 Functioning ‐ specific ‐ social ‐ average endpoint score (SLOF)</h5> <p>There was no clear difference between video games and cognitive remediation for this outcome. Only one small trial used the scale measuring social functioning (n = 53). The SLOF itself is substantial, with 43 items assessing various domains of a person's skills, assets, and abilities (<a href="./references#CD012844-bbs2-0108" title="MucciA , RucciP , RoccaP , BucciP , GibertoniD , MerlottiE , et al. The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community. Schizophrenia Research2014;159(1):144-50. [PMID: 25182540]">Mucci 2014</a>). However, despite the use of 43 items, the clinical meaning of the results remains unclear; we have identified no explanation of what a three‐point difference in rating would mean clinically. We rated the data as of very low quality due to the indirectness of the continuous scale as well as imprecision seen by the width of the confidence intervals. Furthermore, we downgraded the quality of the evidence due to the poor description of randomisation and allocation concealment in the study itself which highlights potential risk of bias. We are very uncertain if this estimate of effect is a true effect. </p> </section> <section id="CD012844-sec-0183"> <h5 class="title">1.4 Adverse effects</h5> <p>None of the included studies measured adverse effects directly.</p> <p>We used leaving the study early as an indirect measure. Five of the included studies addressed loss of participants during the trial, with one study reporting loss of participants for up to a three‐month follow‐up (<a href="./references#CD012844-bbs2-0005" title="ACTRN12616001476426. The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001476426 (first received 17th October 2016). [CSZG: 35303]BryceS , PonsfordJ , LeeS , TanE , CarruthersS , LawrenceR , et al. The impact of cognitive remediation on cognitive and psychosocial outcomes in schizophrenia and the role of intrinsic motivation. Schizophrenia Bulletin2018;44(Suppl 1):S359-60. [CSZG: 38138]BryceSD , LeeSJ , PonsfordJL , LawrenceRJ , TanEJ , RossellSL . The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Schizophrenia Research (in press). [CSZG: 38139]BryceSD , RossellSL , LeeSJ , LawrenceRJ , TanEJ , CarruthersSP , et al. Neurocognitive and self-efficacy benefits of cognitive remediation in schizophrenia: a randomized controlled trial. Journal of the International Neuropsychological Society (in press). [CSZG: 37972]">General CR: Bryce 2018</a>). We have rated this evidence to be low quality due to the majority of studies not accounting for how the loss of participants affected the final result. Furthermore, loss of participants represents a poor metric for adverse effects, and the relevant studies had largely poor descriptions of randomisation and allocation concealment. Again, there was no clear difference between groups. We are uncertain if this estimate of effect is a true effect. </p> </section> <section id="CD012844-sec-0184"> <h5 class="title">1.5 Mental state ‐ overall ‐ average endpoint score (PANSS)</h5> <p>PANSS data were well reported, with four studies giving an overall composite score. Despite being the outcome with the greatest number of participants, data showed no clear distinction between video games and cognitive interventions for effect on overall mental state. Although PANSS is a well‐established scale for assessing positive and negative symptoms for people with schizophrenia, we have rated the evidence as low quality because, once again, data were continuous, as opposed to a binary outcome as pre‐stated in our protocol. Furthermore, the three studies that made up roughly 90% of the weight are at high risk of reporting bias and provide no description of allocation concealment. We are uncertain if this estimate of effect is a true effect. </p> </section> <section id="CD012844-sec-0185"> <h5 class="title">1.6 Physical fitness</h5> <p>No studies in this comparison reported an outcome measuring physical fitness. This is unsurprising as the interventions in this comparison do not involve bodily movement. </p> </section> <section id="CD012844-sec-0186"> <h5 class="title">1.7 Quality of life ‐ overall ‐ average endpoint score (QLS) ‐ short term</h5> <p>One study with 87 participants reported relevant QLS data. There was no clear, statistically significant difference between cognitive remediation and video games for this outcome. We rated the evidence to be of very low quality. Once again, the scale was continuous, and not the binary scale we prespecified in our protocol. The study was also assessed as being at high risk of reporting bias and did not specify its allocation concealment. We are very uncertain if this estimate of effect is a true effect. </p> </section> <section id="CD012844-sec-0187"> <h5 class="title">1.8 Unable to use</h5> <p>Data for aggression were reported using the Overt Aggression Scale (<a href="./references#CD012844-bbs2-0004" title="AhmedA , MarinoB , RosenthalE , OragunyeN , BucknerA . Neurocognitive profiles and cognitive training effects on emotionality and aggression in schizophrenia. Neuropsychopharmacology2015;40:S377. [CSZG: 33272]AhmedAO , HunterKM , GoodrumNM , BattenNJ , BirgenheirD , HardisonE , et al. A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. Journal of Psychiatric Research2015;68:8-18. [CSZG: 33021]">General CR: Ahmed 2015</a>). However, there were only subscores given and not an overall rating for aggression; as per our protocol we did not analyse these subscore data but presented this information as additional data (<a href="#CD012844-tbl-0004">Table 1</a>). Numerous studies have investigated links between video games and an increased composite aggression score (<a href="./references#CD012844-bbs2-0066" title="CalvertSL , AppelbaumM , DodgeKA , GrahamS , Nagayama HallGC , HambyS , et al. The American Psychological Association Task Force assessment of violent video games: science in the service of public interest. American Psychologist2017;72(2):126-43. [PMID: 28221065]">Calvert 2017</a>); it is therefore surprising that outcomes concerning adverse effects are so scarce. We propose that the reasoning for this here is that the video gaming intervention was the control intervention in the vast majority of studies included in this review, and therefore outcomes associated with video games were not the primary focus. </p> <div class="table" id="CD012844-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subscale data ‐ aggression ‐ average endpoint score (Overt Aggression Scale, high = poor)</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="2" valign="bottom"></td> <th align="left" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Video games (non‐exergames)</b> </p> </th> <th align="left" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Cognitive remediation</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SD</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SD</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Object</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐aggression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verbal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </div> </section> </section> <section id="CD012844-sec-0188"> <h4 class="title">2. VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE for schizophrenia (all short term) </h4> <p>See <a href="./full#CD012844-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD012844-sec-0189"> <h5 class="title">2.1 Functioning ‐ general</h5> <p>Regrettably, no studies reported relevant data for this outcome.</p> </section> <section id="CD012844-sec-0190"> <h5 class="title">2.2 Functioning ‐ specific ‐ cognitive ‐ average change score (MCCB, increase = good)</h5> <p>In one small (n = 33) study reported data for this outcome, but did not find any clear difference between treatment groups. Data were of low quality due to the small and imprecise nature of the study, and the use of continuous rather than binary data. We are uncertain if this is a true effect. </p> </section> <section id="CD012844-sec-0191"> <h5 class="title">2.3 Functioning ‐ specific ‐ social</h5> <p>Regrettably, no studies reported relevant data for this outcome.</p> </section> <section id="CD012844-sec-0192"> <h5 class="title">2.4 Adverse effects</h5> <p>Again, no direct measures of adverse effects were reported.</p> <p>One small trial presented data regarding loss, with no statistically significant difference between groups. We rated this evidence as of low quality due to loss to follow‐up being a poor metric for adverse effects, and the small and imprecise nature of the trial in question. We are uncertain if this is a true effect. </p> </section> <section id="CD012844-sec-0193"> <h5 class="title">2.5 Mental state</h5> <p>No studies reported relevant data for this outcome.</p> </section> <section id="CD012844-sec-0194"> <h5 class="title">2.6 Physical fitness ‐ specific ‐ average change VO<sub>2</sub> peak (AF, increase = good) </h5> <p>One small trial reported data for aerobic fitness, with results favouring the exergame group. However, the sample size was very small and the evidence of low quality. We are uncertain if this is a true effect. </p> </section> <section id="CD012844-sec-0195"> <h5 class="title">2.7 Missing outcomes</h5> <p>It is unclear how mental state, quality of life, and general or social functioning are affected by playing exergames. This is an active area of research, and our search found an ongoing study investigating exergames versus an exercise group control (<a href="./references#CD012844-bbs2-0049" title="EnghJA , AndersenE , HolmenTL , MartinsenEW , MordalJ , MorkenG , et al. Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. Trials2015;16(1):557. NCT02205684. Effects of aerobic high intensity training on symptoms, cognition, cortical structure, substance use and metabolic indices in patients with schizophrenia spectrum disorder. Clinicaltrials.gov/show/NCT02205684 (first received July 31, 2014). ">Engh 2015</a>). Their protocol stated that they will measure all of the outcomes that were missing from the one exergame study we did identify, with the exception of general functioning and adverse effects. With an estimated completion date of December 2019, this study could be included in updated versions of this review. </p> </section> </section> <section id="CD012844-sec-0196"> <h4 class="title">3. VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term) </h4> <p>See <a href="./full#CD012844-tbl-0003">summary of findings Table 3</a>. </p> <p>We identified only one outcome corresponding to our pre‐stated main outcomes for this comparison. </p> <section id="CD012844-sec-0197"> <h5 class="title">3.1 Physical fitness ‐ specific ‐ walking speed ‐ average time (seconds taken to walk 3 metres) </h5> <p>One small study reported relevant data for this outcome, demonstrating no clear difference in average walking speeds of the participants. We rated this evidence as of very low quality due to the lack of description of allocation and blinding and method of randomisation. </p> </section> <section id="CD012844-sec-0198"> <h5 class="title">3.2 Missing outcomes</h5> <p>No studies reported data relating to general, social, or cognitive functioning or to adverse effects, mental state, or quality of life. More research is clearly needed in this area. We have not identified any currently ongoing studies that would address these gaps for this comparison. However, one study comparing different non‐exergames is ongoing (<a href="./references#CD012844-bbs2-0054" title="NCT03133143. Video games among people with schizophrenia. clinicaltrials.gov/ct2/show/NCT03133143 (first received April 28, 2017). ">Valimaki 2017</a>), which includes outcomes relating to general, cognitive, and social functioning, as well as to mental state. </p> </section> </section> </section> <section id="CD012844-sec-0199"> <h3 class="title" id="CD012844-sec-0199">Overall completeness and applicability of evidence</h3> <section id="CD012844-sec-0200"> <h4 class="title">1. Completeness</h4> <p>The primary outcomes prespecified for this review were general and cognitive functioning, due to the potential cognitive benefits of video gaming (<a href="./references#CD012844-bbs2-0081" title="GranicI , LobelA , EngelsRC . The benefits of playing video games. American Psychologist2014;69(1):66-78. [PMID: 24295515]">Granic 2014</a>). This really applies to the comparisons where the focus was for a cognitive effect. However exergames, conversely, principally relate to physical fitness, hence cognitive benefits must be considered secondary. Typically, in such trials, only experimental groups are the focus of systematic reviews; changing this dynamic to measure the effect of a control group has been very interesting. The overall completeness of data for cognitive functioning was reasonable; however, there were very limited data for our third primary outcome of adverse effects. Considering the amount of literature condemning video games as related to increased violent behaviour, aggression, and depression (<a href="./references#CD012844-bbs2-0066" title="CalvertSL , AppelbaumM , DodgeKA , GrahamS , Nagayama HallGC , HambyS , et al. The American Psychological Association Task Force assessment of violent video games: science in the service of public interest. American Psychologist2017;72(2):126-43. [PMID: 28221065]">Calvert 2017</a>; <a href="./references#CD012844-bbs2-0126" title="TortoleroSR , PeskinMF , BaumlerER , CuccaroPM , ElliottMN , DaviesSL , et al. Daily violent video game playing and depression in preadolescent youth. Cyberpsychology, Behavior and Social Networking2014;17(9):609-15. [PMID: 25007237]">Tortolero 2014</a>), good reporting of adverse effects was anticipated. Adverse effects are of importance in any study including people with schizophrenia. Cognitive interventions such as cognitive remediation are seeing increasing use, and are now the focus of several meta‐analyses investigating their effect (<a href="./references#CD012844-bbs2-0096" title="KurtzMM , MobergPJ , GurRC , GurRE . Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychology Review2001;11(4):197-210. [PMID: 11883669]">Kurtz 2001</a>), and we would expect better reporting of presence or absence of adverse effects. Furthermore, economic outcomes were not reported at all. This is a major omission in this group of studies, particularly given the anticipated difference in real‐world price between commercial video games and cognitive remediation software. </p> <p>The most disappointing aspect was the poor reporting of data in general. We excluded 32 studies, five of which could otherwise have been included but reported no useable data. Some authors have been most helpful (see <a href="#CD012844-sec-0215">Acknowledgements</a>), but there are still data lost to this review ‐ and any other review that includes these studies. Many studies did measure our outcomes of interest, but did not report average scores or even report data across groups. Data were often presented in a way in which access to the outcome seems to favour access to the original cognitive training groups' numbers. Studies have found robust evidence that results of significance have a much higher chance of being reported compared to non‐significant results (<a href="./references#CD012844-bbs2-0074" title="DwanK , AltmanDG , ArnaizJA , BloomJ , ChanAW , CroninE , et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLOS ONE2008;3(8):e3081. [PMID: 18769481]">Dwan 2008</a>). We have an enduring concern that a bias operates in these data favouring more complete reporting of the cognitive groups' interventions. Furthermore, we had stipulated in the protocol that binary data were to be emphasised. This could be our bias operating, but we continue to argue that binary data eclipse continuous data in clinical usefulness. We are aware that some of the studies were in fact exploratory rather than clinical but, regardless, note that binary outcomes are easy to report, and that their omission is a problem, leaving more clinically orientated researchers using proxy measures and floundering for meaning. </p> </section> <section id="CD012844-sec-0201"> <h4 class="title">2. Applicability</h4> <p>Most trials were conducted in the USA on participants that were clinically stable and being treated as outpatients. Also, studies tended to be carried out in hospital settings ‐ probably because the complex cognitive interventions are usually only available from centres of excellence. However, the majority of people with schizophrenia are treated in community settings ‐ and this is where people play video games. Should any benefit emerge in future studies of the non‐exer‐video games or the cognitive training, such studies should also be home‐based. Should there be any more exergame studies, it would seem important that these are undertaken in more real‐world settings. </p> </section> </section> <section id="CD012844-sec-0202"> <h3 class="title" id="CD012844-sec-0202">Quality of the evidence</h3> <p>On the whole, the quality of the evidence was not good, and no trial was completely free of potential bias. None of the included trials specified their method of allocation concealment, and a number of trials had potential reporting bias. Blinding, however, was well reported by all studies. See <a href="#CD012844-fig-0003">Figure 3</a> for a visual representation of the quality of the included studies. </p> </section> <section id="CD012844-sec-0203"> <h3 class="title" id="CD012844-sec-0203">Potential biases in the review process</h3> <p>We are currently unable to detect any publication bias due to the small number of trials. Experiments with games could well be part of dissertations or theses that we have failed to identify. Two of the included studies were written in languages other than English (Mandarin and Spanish). There is always the possibility of searches incorporating a language bias, but we have no clear suggestion of this. </p> <p>Another problem that could have arisen is that in all studies involving non‐exergame video games, these were the control groups for other better described interventions. It is possible that we failed to identify further studies because description of the control group (video game) was not been mentioned in the report. </p> </section> <section id="CD012844-sec-0204"> <h3 class="title" id="CD012844-sec-0204">Agreements and disagreements with other studies or reviews</h3> <p>We know of no other study systematically investigating the effect of commercial video games for people with schizophrenia. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012844-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram for 2018 and 2019 searches." data-id="CD012844-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram for 2018 and 2019 searches.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Xbox 360 Kinect." data-id="CD012844-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-02.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Xbox 360 Kinect.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-02.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012844-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012844-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 1: Functioning: 1a. General ‐ average endpoint score (various scales, high = good) ‐ by end of treatment" data-id="CD012844-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 1: Functioning: 1a. General ‐ average endpoint score (various scales, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 2: Functioning: 1b. General ‐ average endpoint score (ILSS, high = good) ‐ 3‐month follow‐up" data-id="CD012844-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 2: Functioning: 1b. General ‐ average endpoint score (ILSS, high = good) ‐ 3‐month follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 3: Functioning: 2a. Specific ‐ cognitive ‐ improved (MCCB, at least one domain) ‐ by end of treatment" data-id="CD012844-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 3: Functioning: 2a. Specific ‐ cognitive ‐ improved (MCCB, at least one domain) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 4: Functioning 2b. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ by end of treatment" data-id="CD012844-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 4: Functioning 2b. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 5: Functioning 2c. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ 3‐month follow‐up" data-id="CD012844-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 5: Functioning 2c. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ 3‐month follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0010"> <p> <div class="table" id="CD012844-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Functioning 2d. Specific ‐ cognitive ‐ average endpoint score (MATRICS ‐ z scores, high = good) ‐ by end of treatment (skewed data) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>N</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Aud CR: Fisher 2014</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Video games (commercial non‐exergame)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive remediation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Aud CR: Vinogradov 2014</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Video games (commercial non‐exergame)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive remediation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 6: Functioning 2d. Specific ‐ cognitive ‐ average endpoint score (MATRICS ‐ z scores, high = good) ‐ by end of treatment (skewed data) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0010">Navigate to figure in review</a></div> </div> <div class="figure" id="CD012844-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 7: Functioning 2e. Specific ‐ cognitive ‐ average endpoint score (CAI, high = poor) ‐ by end of treatment" data-id="CD012844-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 7: Functioning 2e. Specific ‐ cognitive ‐ average endpoint score (CAI, high = poor) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 8: Functioning: 3a. Specific ‐ social ‐ average endpoint score (Global Functioning: Role and Social Scale, high = good) ‐ by end of treatment" data-id="CD012844-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 8: Functioning: 3a. Specific ‐ social ‐ average endpoint score (Global Functioning: Role and Social Scale, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 9: Functioning: 3b. Specific ‐ social ‐ average endpoint score (SLOF, high = good) ‐ by end of treatment" data-id="CD012844-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 9: Functioning: 3b. Specific ‐ social ‐ average endpoint score (SLOF, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 10: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ by end of treatment" data-id="CD012844-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 10: Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 11: Mental state: 1b. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ 3‐month follow‐up" data-id="CD012844-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 11: Mental state: 1b. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ 3‐month follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 12: Mental state: 2a. Specific ‐ negative ‐ average endpoint score (PANSS negative, high = poor) ‐ by end of treatment" data-id="CD012844-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 12: Mental state: 2a. Specific ‐ negative ‐ average endpoint score (PANSS negative, high = poor) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 13: Mental state: 2b. Specific ‐ positive ‐ average endpoint score (PANSS positive, high = poor) ‐ by end of treatment" data-id="CD012844-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 13: Mental state: 2b. Specific ‐ positive ‐ average endpoint score (PANSS positive, high = poor) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0018"> <p> <div class="table" id="CD012844-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Global state: Average endpoint score (CGI ‐ severity, high = poor) ‐ by end of treatment (skewed data) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>N</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Aud CR: Keefe 2012</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Video games (commercial non‐exergame)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive remediation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 14: Global state: Average endpoint score (CGI ‐ severity, high = poor) ‐ by end of treatment (skewed data) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0018">Navigate to figure in review</a></div> </div> <div class="figure" id="CD012844-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 15: Leaving the study early: Did not leave" data-id="CD012844-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 15: Leaving the study early: Did not leave </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 16: Quality of life: 1a. Overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment" data-id="CD012844-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 16: Quality of life: 1a. Overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 17: Quality of life: 1b. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ by end of treatment" data-id="CD012844-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 17: Quality of life: 1b. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 18: Quality of life: 1c. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ 3‐month follow‐up" data-id="CD012844-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 18: Quality of life: 1c. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ 3‐month follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 19: Quality of life: 2a. Specific ‐ well‐being ‐ improved (IMI‐SR increase in score, high = good) ‐ by end of treatment" data-id="CD012844-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 19: Quality of life: 2a. Specific ‐ well‐being ‐ improved (IMI‐SR increase in score, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 20: Quality of life: 2b. Specific ‐ well‐being ‐ average endpoint score (various scales, high = good) ‐ by end of treatment" data-id="CD012844-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 20: Quality of life: 2b. Specific ‐ well‐being ‐ average endpoint score (various scales, high = good) ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 21: Quality of life: 2c. Specific ‐ well‐being ‐ average endpoint score (Revised Self‐Efficacy Scale, high = good) ‐ 3‐month follow‐up" data-id="CD012844-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term), Outcome 21: Quality of life: 2c. Specific ‐ well‐being ‐ average endpoint score (Revised Self‐Efficacy Scale, high = good) ‐ 3‐month follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 1: Functioning: 1a. Specific ‐ cognitive ‐ average change score (MCCB, increase = good)" data-id="CD012844-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 1: Functioning: 1a. Specific ‐ cognitive ‐ average change score (MCCB, increase = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 2: Physical fitness: 2a. Specific ‐ average change (BDNF, increase = good)" data-id="CD012844-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 2: Physical fitness: 2a. Specific ‐ average change (BDNF, increase = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 3: Physical fitness: 2b. Specific ‐ average change VO2 peak (AF, increase = good)" data-id="CD012844-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 3: Physical fitness: 2b. Specific ‐ average change VO<sub>2</sub> peak (AF, increase = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 4: Leaving the study early: Did not leave ‐ by end of treatment" data-id="CD012844-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term), Outcome 4: Leaving the study early: Did not leave ‐ by end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 1: Physical fitness: 1a. Specific ‐ walking speed ‐ average time (seconds taken to walk 3 metres, low = good)" data-id="CD012844-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 1: Physical fitness: 1a. Specific ‐ walking speed ‐ average time (seconds taken to walk 3 metres, low = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 2: Physical fitness: 1b. Specific ‐ average endpoint score (SPPB, high = good)" data-id="CD012844-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 2: Physical fitness: 1b. Specific ‐ average endpoint score (SPPB, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 3: Behaviour: 2a. Specific ‐ average number of sessions attended (of 6 in total)" data-id="CD012844-fig-0032" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 3: Behaviour: 2a. Specific ‐ average number of sessions attended (of 6 in total) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012844-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/urn:x-wiley:14651858:media:CD012844:CD012844-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 4: Behaviour: 2b. Specific ‐ average time (minutes) at sessions (of 180 minutes in total)" data-id="CD012844-fig-0033" src="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_t/tCD012844-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term), Outcome 4: Behaviour: 2b. Specific ‐ average time (minutes) at sessions (of 180 minutes in total) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/media/CDSR/CD012844/image_n/nCD012844-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD012844-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Reviews suggested by excluded trials</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="1" valign="bottom"></td> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Suggested title or link to existing review</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0031" title="LoewyR , FisherM , MathalonDH , VinogradovS . Interim analyses of a randomized controlled trial of computerized cognitive training in clinical high risk for psychosis. Schizophrenia Bulletin2013;39:S238-9. LoewyR , FisherM , SchlosserDA , BiagiantiB , StuartB , MathalonDH , et al. Intensive auditory cognitive training improves verbal memory in adolescents and young adults at clinical high risk for psychosis. Schizophrenia Bulletin2016;42(Suppl 1):S118-26. NCT00655239. Effectiveness of neuroadaptive cognitive training in adolescents at risk for psychosis. clinicaltrials.gov/ct2/show/NCT00655239 (first received April 9, 2008). ">Loewy 2013</a>; </p> <p><a href="./references#CD012844-bbs2-0026" title="NCT02404194. Targeted cognitive training in clinical high risk (CHR) for psychosis. clinicaltrials.gov/ct2/show/NCT02404194 (first received March 31, 2015). ">Hooker 2019</a>; </p> <p><a href="./references#CD012844-bbs2-0037" title="NCT01619319. Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. ClinicalTrials.gov/show/NCT01619319 (first received June 14, 2012). PiskulicD , BarbatoM , AddingtonJ . Cognitive remediation in young people at clinical high risk of psychosis. Early Intervention in Psychiatry2012;6:89. PiskulicD , BarbatoM , AddingtonJ . Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. Schizophrenia Research2012;136:S245-6. PiskulicD , BarbatoM , LiuL , AddingtonJ . Effects of cognitive remediation on cognition in young people at clinical high risk of psychosis. Schizophrenia Research2014;153(Suppl 1):S218. PiskulicD , BarbatoM , LiuL , AddingtonJ . Effects of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Early Intervention in Psychiatry2014;8:86. ">Piskulic 2012</a>; </p> <p><a href="./references#CD012844-bbs2-0014" title="CangasAJ , NavarroN , ParraJMA , OjedaJJ , CangasD , PiedraJA , et al. Stigma-Stop: a serious game against the stigma toward mental health in educational settings. Frontiers in Psychology2017;8:1385. ">Cangas 2017</a>; </p> <p><a href="./references#CD012844-bbs2-0022" title="GyllenstenAL , ForsbergKA . Computerized physical activity training for persons with severe mental illness - experiences from a communal supported housing project. Disability and Rehabilitation: Assistive Technology2017;12(8):780-8. ">Gyllensten 2017</a>; </p> <p><a href="./references#CD012844-bbs2-0030" title="KoikeS , YamaguchiS , OjioY , AndoS . Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype. Psychiatry Research2018;261:264-8. KoikeS , YamaguchiS , OjioY , OhtaK , ShimadaT , WatanabeK , et al. A randomised controlled trial of repeated filmed social contact on reducing mental illness-related stigma in young adults. Epidemiology and Psychiatric Sciences2018;27:199-208. UMIN000012239. An open-label parallel group randomized controlled trial for investigating the efficacy and persistence of internet self-learning and filmed social contact for reducing stigma in the university students. https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013570 (first received 10 November 2013). YamaguchiS , KoikeS , OjioY , ShimadaT , WatanabeKI , AndoS . Filmed social contact v. internet self-learning to reduce mental health-related stigma among university students in Japan: a randomized controlled trial. Early Intervention in Psychiatry2014;8:52. ">Koike 2018</a>; </p> <p><a href="./references#CD012844-bbs2-0038" title="PiskulicD , BarbatoM , LiuL , AddingtonJ . Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Research2015;225(1-2):93-8. ">Piskulic 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with high risk of psychosis, not people with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Video game vs other treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Video games for people at high risk of psychosis</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0010" title="BellMD . Cognitive training to enhance work program outcomes: preliminary findings. Schizophrenia Bulletin2015;41:S302. ">Bell 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="11" valign="top"> <p>People with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Posit Science vs Nintendo BrainAge</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="12" valign="top"> <p>Cognitive training for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0011" title='BellMD , LawsH , PittmanB , JohannesenJK . Comparison of focused cognitive training and portable "brain-games" on functional outcomes for vocational rehabilitation participants. Scientific Reports2018;8(1):1779. NCT00829400. Cognitive training to enhance VA work program outcomes. clinicaltrials.gov/ct2/show/NCT00829400 (first received January 27, 2009). '>Bell 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Posit Science vs Nintendo BrainAge</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0017" title="ChoiKH , KangJ , KimSM , LeeSH , ParkSC , LeeWH , et al. Efficacy of computer assisted cognitive remediation in mid-aged and older inpatients with chronic schizophrenia in Korea. Schizophrenia Bulletin2018;44(Suppl 1):S240-1. ">Choi 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive remediation (computer assisted) with psychiatric rehabilitation vs psychiatric rehabilitation </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0020" title="DomenA . The cognition game study. http://isrctn.com/2017. ">Domen 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive training through playing AquaSnap video game vs treatment as usual</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0021" title="FisherM , NahumM , HowardE , RowlandsA , BrandrettB , KermottA , et al. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: an interim report. Psychiatric Rehabilitation Journal2017;40(1):21-32. [PMID: 28368179]">Fisher 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Targeted cognitive training vs social cognition training</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0047" title="ZhangW , ShilukA , RackelmannS , TarasenkoM , ThomasM , BismarkA , et al. The 40-HZ auditory steady-state response: a sensitive and predictive biomarker of perceptual learning during cognitive training. Schizophrenia Bulletin2017;43:S183-4. ">Zhang 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐auditory video games vs targeted cognitive training</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0055" title="NCT01988714. Cognitive remediation of schizophrenia in a community mental health setting. Clinicaltrials.gov/show/NCT01988714 (first received November 20, 2013). ">Vinogradov 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Online auditory and social cognitive training vs free‐choice online cognitive exercises</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0013" title="NCT02584114. Brain effects of memory training in early psychosis. clinicaltrials.gov/ct2/show/NCT02584114 (first received October 22, 2015). ">Buchy 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Memory vs non‐memory training group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0044" title="NCT02782442. Cognitive training delivered remotely to individuals with schizophrenia. clinicaltrials.gov/ct2/show/NCT02782442 (first recieved May 25, 2016). ">Vinogradov 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Online auditory and social cognitive training vs free‐choice online cognitive exercises</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0046" title="ZhangQ , YuanY , SunL , RenQ , ZhangL . The effect of group psychological game therapy on the quality of life of patients with schizophrenia.. Chinese Journal of Health Psychology2014;22(11):1705-8. ">Zhang 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychological play therapy</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0048" title="ZhouY , ZhengY . The clinical effect of team mental games on patients with schizophrenia during rehabilitation. Chinese Prescription Drugs2014;12(6):92-3. ">Zhou 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychological games</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0034" title="NiemanDH , DomenAC , KumarR , HarrisonJ , De HaanL , DenysDA . Cognitive remediation in psychiatric patients with an online cognitive game and assessment tool. European Neuropsychopharmacology2015;25:S344-5. ">Nieman 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OCD, schizophrenia/schizoaffective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Monster Valley cognition game vs TAU</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0015" title="CavezianC , Berquand-MerleM , FranckN , DemilyC . Chess self-training for cognitive remediation in schizophrenia. Schizophrenia Research2008;98:53. ">Cavezian 2008</a>; <a href="./references#CD012844-bbs2-0019" title="DemilyC , CavezianC , DesmurgetM , Berquand-MerleM , ChambonV , FranckN . The game of chess enhances cognitive abilities in schizophrenia. Schizophrenia Research2009;107(1):112-3. [PMID: 18995990]">Demily 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>People with schizophrenia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chess playing vs TAU</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Non‐video games for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0016" title="ChoiJ , MedaliaA . Intrinsic motivation and learning in a schizophrenia spectrum sample. Schizophrenia Research2010;118(1-3):12-9. ">Choi 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motivational math game vs math game</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0043" title="TurveyAA , MainCJ , McMartneyA . Social activity groups with chronic schizophrenics: the influence of the therapist's behaviour. British Journal of Occupational Therapy1985;48:302-4. ">Turvey 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Playing cards</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0042" title="TorresA , MendezLP , MerinoH , MoranEA . Improving social functioning in schizophrenia by playing the train game. Psychiatric Services (Washington, D.C.)2002;53(7):799-801. [PMID: 12096159]">Torres 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Train Game vs occupational therapy</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0042" title="TorresA , MendezLP , MerinoH , MoranEA . Improving social functioning in schizophrenia by playing the train game. Psychiatric Services (Washington, D.C.)2002;53(7):799-801. [PMID: 12096159]">Torres 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Train Game vs occupational therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Occupational therapy for people with schizophrenia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0029" title="KellyL . Trivia Psychotica: the Development and Evaluation of an Educational Game for the Revision of Psychotic Disorders in an RMN. Training Programme [Degree in Nursing Dissertation]. University of Ulster, 1992. KellyS . Trivia-psychotica: the development and evaluation of an educational game for the revision of psychiatric disorders in a nurse training programme. Journal of Psychiatric and Mental Health Nursing1995;2(6):366-7. [MEDLINE: 8696789]">Kelly 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nurse trainees</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trivia Psychotica game vs standard care, not video games</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0062" title="BhoopathiPS , SheoranR . Educational games for mental health professionals. Cochrane Database of Systematic Reviews2006, Issue 2. Art. No: CD001471. [DOI: 10.1002/14651858.CD001471.pub2] [PMID: 16625545]">Bhoopathi 2006</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012844-bbs2-0009" title="BarnettO . Nonprofessionals in the rehabilitation of mentally disordered sex offenders. Community Mental Health Journal1978;14(2):110-5. [PMID: 699527]">Barnett 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mentally disordered sex offenders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Group encounters vs hobby and game control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Group treatment for mentally disorder sex offenders; games for mentally disorder sex offenders </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>OCD: obsessive–compulsive disorder<br/>TAU: treatment as usual </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Reviews suggested by excluded trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012844-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Methods</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation: randomised ‐ method described.</p> <p>Allocation concealed ‐ method described.</p> <p>Blinding: none.</p> <p>Duration: 30 minutes, twice a week for 10 weeks with a 3‐, 6‐, and 9‐month follow‐up.</p> <p>Setting: community mental health setting.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis: DSM‐IV Axis I diagnosis of schizophrenia or schizophrenia‐like illnesses.<br/>N = 300.*<br/>Age: 18 to 40.<br/>Sex: any. </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Interventions</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Exergame/non‐exergame** + treatment as usual. N = 150.</p> <p>2. Treatment as usual. N = 150.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning ‐ general: compliance with treatment, CGI ‐ clinically important changes.</p> <p>Functioning ‐ physical: SPPB.<br/>Functioning ‐ social: employed, relationship status.<br/>Adverse effects: relapse, hospitalisation, BPAQ, any recorded adverse effects.<br/>Mental state: PANSS.<br/>Quality of life: QOL.<br/>Economic outcomes: costs of intervention. </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*For binary outcome, for 20% difference in groups, usually about 150 people in each group is needed to achieve adequate power. </p> <p>**We express no preference for which of the broad classes of games should be the focus of a new trial. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>BPAQ: Buss‐Perry Aggression Questionnaire<br/>CGI: Clinical Global Impression<br/>DSM: Diagnostic and Statistical Manual of Mental Disorders<br/>PANSS: Positive and Negative Syndrome Scale<br/>QOL: Quality of Life Questionnaire<br/>SPPB: Short Physical Performance Battery </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Suggested design of study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012844-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION (plus standard care) for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION for people with schizophrenia (plus standard care) (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> inpatient and outpatient<br/><b>Intervention:</b> video games (commercial non‐exergames)<br/><b>Comparison:</b> cognitive remediation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with cognitive remediation</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (commercial non‐exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ average endpoint score (Strauss Carpenter Outcome Scale)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.42 higher<br/>(0.62 lower to 1.46 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ improved (MCCB, at least 1 domain) ‐ 3‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>773 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>448 per 1000<br/>(263 to 765) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.58<br/>(0.34 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ average endpoint score (SLOF, high = good)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.13 lower<br/>(40.17 lower to 33.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects*: leaving the study early ‐ did not leave ‐ by end of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>232 per 1000<br/>(156 to 342) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96 (0.87 to 1.06)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>395<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*No studies directly reported on adverse effects.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ average endpoint score (PANSS, total, high = poor)* ‐ by end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.20 higher<br/>(3.89 lower to 4.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>269<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness: clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported on this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 higher<br/>(0.40 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by 1 ‐ randomisation and concealment of allocation not well described.<br/><sup>2</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol.<br/><sup>3</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals.<br/><sup>4</sup>Indirectness: downgraded by 1 ‐ leaving the study is proxy for adverse effects and may not even represent a negative event/effect. </p> <p>MCCB: (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery<br/>PANSS: Positive and Negative Syndrome Scale<br/>SLOF: Specific Levels of Functioning<br/>QLS: Quality of Life Scale </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) compared to COGNITIVE REMEDIATION (plus standard care) for people with schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012844-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> video games (exergames)<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ average change score (MCCB, increase = good)*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.90 higher<br/>(1.27 lower to 7.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects*: leaving the study early ‐ did not leave</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>765 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>811 per 1000<br/>(574 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.06<br/>(0.75 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*No studies directly reported on adverse effects.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness*: average change VO<sub>2</sub> peak (AF, increase = good) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.82 higher</p> <p>(1.75 higher to 5.89 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ any change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol.<br/><sup>2</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals.<br/><sup>3</sup>Indirectness: downgraded by 1 ‐ leaving the study is proxy for adverse effects and may not even represent a negative event/effect.<br/><sup>4</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol; aerobic fitness is proxy for physical fitness and may not correspond to clinically important change. </p> <p>AF: aerobic fitness<br/>MCCB: (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery<br/>VO<sub>2</sub> peak: peak oxygen uptake </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to STANDARD CARE for people with schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012844-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia (all short term)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> video games (exergames) (plus standard care)<br/><b>Comparison:</b> video games (non‐exergames) (plus standard care) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (non‐exergames)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with video games (exergames)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: general ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ cognitive ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: specific ‐ social ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome. studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effect: any important adverse effect</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mental state: overall ‐ clinically important change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physical fitness: specific ‐ walking speed ‐ average endpoint (seconds taken to walk 3 metres)* </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 seconds lower<br/>(1.17 lower to 0.17 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊝⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>*Clinically important change data not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: overall ‐ any change</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trials reported this important outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High</b> quality<b>:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate</b> quality<b>:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low</b> quality<b>:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low</b> quality<b>:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: downgraded by 2 ‐ method of randomisation not described; allocation and blinding not described.<br/><sup>2</sup>Indirectness: downgraded by 1 ‐ continuous data when binary stipulated in protocol; walking speed is proxy for physical fitness and may not correspond to clinically important change.<br/><sup>3</sup>Imprecision: downgraded by 1 ‐ small trial, wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) compared to VIDEO GAMES (NON‐EXERGAMES) (plus standard care) for people with schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012844-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subscale data ‐ aggression ‐ average endpoint score (Overt Aggression Scale, high = poor)</span></div> <tbody> <tr> <td align="left" class="headercell" colspan="1" rowspan="2" valign="bottom"></td> <th align="left" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Video games (non‐exergames)</b> </p> </th> <th align="left" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Cognitive remediation</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SD</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SD</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Object</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Self‐aggression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verbal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subscale data ‐ aggression ‐ average endpoint score (Overt Aggression Scale, high = poor)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/full#CD012844-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012844-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Functioning: 1a. General ‐ average endpoint score (various scales, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 ILSS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.04, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 MARS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.42, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Strauss Carpenter Outcome Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐0.62, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 UPSA ‐ total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [‐29.92, 33.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.5 UPSA ‐ communication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐3.33, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.6 UPSA ‐ comprehension/planning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐3.97, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.7 UPSA ‐ financial management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐1.71, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.8 UPSA ‐ transportation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.88 [‐3.05, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Functioning: 1b. General ‐ average endpoint score (ILSS, high = good) ‐ 3‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.03, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Functioning: 2a. Specific ‐ cognitive ‐ improved (MCCB, at least one domain) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.34, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Functioning 2b. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.60 [‐6.43, ‐0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Functioning 2c. Specific ‐ cognitive ‐ average endpoint score (MCCB ‐ composite, high = good) ‐ 3‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.69 [‐9.52, 4.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Functioning 2d. Specific ‐ cognitive ‐ average endpoint score (MATRICS ‐ z scores, high = good) ‐ by end of treatment (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Functioning 2e. Specific ‐ cognitive ‐ average endpoint score (CAI, high = poor) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.25, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Functioning: 3a. Specific ‐ social ‐ average endpoint score (Global Functioning: Role and Social Scale, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Global functioning role</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐1.15, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Global functioning social</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.43, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Functioning: 3b. Specific ‐ social ‐ average endpoint score (SLOF, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.13 [‐40.17, 33.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Mental state: 1a. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐3.89, 4.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Mental state: 1b. Overall ‐ average endpoint score (PANSS total, high = poor) ‐ 3‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.58 [‐15.31, 4.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Mental state: 2a. Specific ‐ negative ‐ average endpoint score (PANSS negative, high = poor) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐1.63, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Mental state: 2b. Specific ‐ positive ‐ average endpoint score (PANSS positive, high = poor) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐2.21, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Global state: Average endpoint score (CGI ‐ severity, high = poor) ‐ by end of treatment (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Leaving the study early: Did not leave <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 By end of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 Follow‐up (3 to 9 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.83, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Quality of life: 1a. Overall ‐ average endpoint score (QLS, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.40, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Quality of life: 1b. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐3.34, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Quality of life: 1c. Overall ‐ average endpoint score (EUROHIS‐QOL, high = good) ‐ 3‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [‐2.69, 3.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Quality of life: 2a. Specific ‐ well‐being ‐ improved (IMI‐SR increase in score, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.70, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 Quality of life: 2b. Specific ‐ well‐being ‐ average endpoint score (various scales, high = good) ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.1 IMI‐SR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [‐1.22, 11.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.2 PCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [‐2.62, 3.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.3 Rosenberg Self‐Esteem Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐3.34, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.4 Revised Self‐Efficacy Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.41 [‐4.85, 23.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 Quality of life: 2c. Specific ‐ well‐being ‐ average endpoint score (Revised Self‐Efficacy Scale, high = good) ‐ 3‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.13 [‐7.17, 19.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) versus COGNITIVE REMEDIATION (plus standard care) (all short term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012844-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Functioning: 1a. Specific ‐ cognitive ‐ average change score (MCCB, increase = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [‐1.27, 7.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Physical fitness: 2a. Specific ‐ average change (BDNF, increase = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐3.43, 3.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Physical fitness: 2b. Specific ‐ average change VO<sub>2</sub> peak (AF, increase = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.82 [1.75, 5.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Leaving the study early: Did not leave ‐ by end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.75, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) versus STANDARD CARE (all short term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012844-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Physical fitness: 1a. Specific ‐ walking speed ‐ average time (seconds taken to walk 3 metres, low = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐1.17, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Physical fitness: 1b. Specific ‐ average endpoint score (SPPB, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.98, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Behaviour: 2a. Specific ‐ average number of sessions attended (of 6 in total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.48, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Behaviour: 2b. Specific ‐ average time (minutes) at sessions (of 180 minutes in total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.20 [‐17.66, 13.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">VIDEO GAMES (EXERGAMES) (plus standard care) versus NON‐EXERGAMES (plus standard care) (all short term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012844.pub2/references#CD012844-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012844.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012844-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012844-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012844-note-0018">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD012844-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD012844-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012844-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012844-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012844-note-0012">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012844-note-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012844-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012844\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012844\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012844\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012844\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012844\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012844.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012844.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012844.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012844.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012844.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729568835"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012844.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729568839"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012844.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee0116bf1bd65',t:'MTc0MDcyOTU2OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 